Search
All Clinical Trials in Canada
A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
301 - 312 of 3905
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)
Recruiting
Atrial fibrillation (AF) is a type of irregular heart rhythm due to electrical signal disturbances of the heart. It is a very common arrhythmia and the risk of developing AF increases with age and with other risk factors such as diabetes, high blood pressure, and underlying heart disease. The main complications of AF are heart failure and stroke. However, studies have shown that restoration of normal rhythm does not reduce these complications. Rather, these complications are mitigated by control... Read More
Atrial fibrillation (AF) is a type of irregular heart rhythm due to electrical signal disturbances of the heart. It is a very common arrhythmia and the risk of developing AF increases with age and with other risk factors such as diabetes, high blood pressure, and underlying heart disease. The main complications of AF are heart failure and stroke. However, studies have shown that restoration of normal rhythm does not reduce these complications. Rather, these complications are mitigated by controlling the heart rate and using blood thinners to prevent stroke. Symptoms secondary to AF can occur due to the irregular heart rate and poor contraction in the atria, the top chambers of the heart. These symptoms include shortness of breath, fatigue, reduced exercise tolerance, and palpitations. Restoring sinus rhythm can sometimes alleviate these symptoms. Given that studies to date have not shown a difference in hard clinical endpoints between rate and rhythm control strategies, the decision to proceed with rhythm control depends on the patient symptom burden.
Rhythm control strategies in patients with persistent AF include cardioversion back to sinus rhythm with long-term recurrence prevention via anti-arrhythmic drugs (AADs) or catheter ablation. However, many studies of these procedures omit a sham placebo control arm. No atrial fibrillation procedural intervention has been compared to a sham procedure. The cardioversion procedure can easily be compared to a "sham" alternative, as it is non-invasive with an expected response within days-to-weeks. Thus, a cardioversion versus "sham" cardioversion trial will allow us to truly assess the impact of a rhythm-control strategy on QOL. It is hypothesized that cardioversion of atrial fibrillation leads to significant improvement in quality of life (QOL) compared to sham cardioversion.
Understanding the true QOL impact of sinus rhythm restoration in patients with persistent AF is of significant importance in guiding strategies for the management of AF. Hence, by evaluating what the true effect of cardioversion on QOL in this blinded study, we can better understand the role of medical management and AF ablation in our patients and assess resource allocation to these procedures. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: University of Ottawa Heart Institute, Ottawa, Ontario
University of Ottawa Heart Institute, Ottawa, Ontario
Conditions: Atrial Fibrillation
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
Recruiting
The primary objective of this study to evaluate efficacy of ravulizumab compared with placebo on proteinuria reduction and change in eGFR in adult participants with IgAN who are at risk of disease progression.
The primary objective of this study to evaluate efficacy of ravulizumab compared with placebo on proteinuria reduction and change in eGFR in adult participants with IgAN who are at risk of disease progression. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: Research Site, Alabaster, Alabama +322 locations
Research Site, Alabaster, Alabama
Research Site, Phoenix, Arizona
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, Orange, California
Research Site, San Bernardino, California
Research Site, San Diego, California
Research Site, San Francisco, California
Research Site, Stanford, California
Research Site, Torrance, California
Research Site, Valencia, California
Research Site, Aurora, Colorado
Research Site, Bay Pines, Florida
Research Site, Miami, Florida
Research Site, Orlando, Florida
Research Site, Acworth, Georgia
Research Site, Atlanta, Georgia
Research Site, Lawrenceville, Georgia
Research Site, Meridian, Idaho
Research Site, Iowa City, Iowa
Research Site, New Orleans, Louisiana
Research Site, Shreveport, Louisiana
Research Site, Augusta, Maine
Research Site, Boston, Massachusetts
Research Site, Boston, Massachusetts
Research Site, Boston, Massachusetts
Research Site, Worcester, Massachusetts
Research Site, Pontiac, Michigan
Research Site, Minneapolis, Minnesota
Research Site, Minneapolis, Minnesota
Research Site, Kansas City, Missouri
Research Site, Saint Peters, Missouri
Research Site, North Las Vegas, Nevada
Research Site, Albany, New York
Research Site, Bronx, New York
Research Site, East Setauket, New York
Research Site, New York, New York
Research Site, Columbus, Ohio
Research Site, Charleston, South Carolina
Research Site, Knoxville, Tennessee
Research Site, Arlington, Texas
Research Site, Houston, Texas
Research Site, Houston, Texas
Research Site, San Antonio, Texas
Research Site, Shenandoah, Texas
Research Site, Temple, Texas
Research Site, Charlottesville, Virginia
Research Site, Milwaukee, Wisconsin
Research Site, Buenos Aires, Not set
Research Site, Ciudad de Buenos Aires, Not set
Research Site, Córdoba, Not set
Research Site, Florencio Varela, Not set
Research Site, La Plata, Not set
Research Site, Rosario, Not set
Research Site, San Luis, Not set
Research Site, Camperdown, Not set
Research Site, Canberra, Not set
Research Site, Clayton, Not set
Research Site, Concord, Not set
Research Site, Herston, Not set
Research Site, Liverpool, Not set
Research Site, Parkville, Not set
Research Site, Perth, Not set
Research Site, Southport, Not set
Research Site, St Albans, Not set
Research Site, Graz, Not set
Research Site, Innsbruck, Not set
Research Site, Linz, Not set
Research Site, Brussel, Not set
Research Site, Edegem, Not set
Research Site, Leuven, Not set
Research Site, Liège, Not set
Research Site, Roeselare, Not set
Research Site, Belo Horizonte, Not set
Research Site, Belo Horizonte, Not set
Research Site, Belo Horizonte, Not set
Research Site, Botucatu, Not set
Research Site, Curitiba, Not set
Research Site, Fortaleza, Not set
Research Site, Recife, Not set
Research Site, Ribeirão Preto, Not set
Research Site, Salvador, Not set
Research Site, São José do Rio Preto, Not set
Research Site, São Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Winnipeg, Manitoba
Research Site, London, Ontario
Research Site, Ottawa, Ontario
Research Site, Toronto, Ontario
Research Site, Araucania, Not set
Research Site, Providencia, Not set
Research Site, Santiago, Not set
Research Site, Santiago, Not set
Research Site, Valdivia, Not set
Research Site, Baotou, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changsha, Not set
Research Site, Changzhou, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Jinan, Not set
Research Site, Jinan, Not set
Research Site, Jinhua, Not set
Research Site, Lanzhou, Not set
Research Site, Luoyang, Not set
Research Site, Nanchang, Not set
Research Site, Nanchang, Not set
Research Site, Nanjing, Not set
Research Site, Nanjing, Not set
Research Site, Nanjing, Not set
Research Site, Ningbo, Not set
Research Site, Qingdao, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenzhen, Not set
Research Site, Shenzhen, Not set
Research Site, Urumqi, Not set
Research Site, Wuhan, Not set
Research Site, Wuxi, Not set
Research Site, Xian, Not set
Research Site, Yantai, Not set
Research Site, Yibin, Not set
Research Site, Yinchuan, Not set
Research Site, Zhanjiang, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhongshan, Not set
Research Site, Barranquilla, Not set
Research Site, Bogota, Not set
Research Site, Cali, Not set
Research Site, Manizales, Not set
Research Site, Medellín, Not set
Research Site, Rionegro, Not set
Research Site, Nový Jičín, Not set
Research Site, Praha, Not set
Research Site, Praha, Not set
Research Site, Amiens, Not set
Research Site, Bayonne, Not set
Research Site, Brest Cedex, Not set
Research Site, Chambéry, Not set
Research Site, Clermont-Ferrand, Not set
Research Site, Le Kremlin-Bicêtre, Not set
Research Site, Marseille, Not set
Research Site, Nantes, Not set
Research Site, Nice, Not set
Research Site, Paris, Not set
Research Site, Paris, Not set
Research Site, Paris, Not set
Research Site, Saint-Priest-en-Jarez, Not set
Research Site, Strasbourg, Not set
Research Site, Toulouse, Not set
Research Site, Aachen, Not set
Research Site, Berlin, Not set
Research Site, Erlangen, Not set
Research Site, Essen, Not set
Research Site, Greifswald, Not set
Research Site, Hannover, Not set
Research Site, Konstanz, Not set
Research Site, Köln, Not set
Research Site, Mainz, Not set
Research Site, München, Not set
Research Site, München, Not set
Research Site, Villingen-Schwenningen, Not set
Research Site, Athens, Not set
Research Site, Athens, Not set
Research Site, Heraclion, Not set
Research Site, Patras, Not set
Research Site, Thessaloniki, Not set
Research Site, HKG, Not set
Research Site, Hong Kong, Not set
Research Site, Hong Kong, Not set
Research Site, Lai Chi Kok, Not set
Research Site, Budapest, Not set
Research Site, Miskolc, Not set
Research Site, Haifa, Not set
Research Site, Jerusalem, Not set
Research Site, Nazareth, Not set
Research Site, Petah Tikva, Not set
Research Site, Tel Aviv, Not set
Research Site, Agrigento, Not set
Research Site, Bari, Not set
Research Site, Bologna, Not set
Research Site, Brescia, Not set
Research Site, Cagliari, Not set
Research Site, Firenze, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, Padova, Not set
Research Site, Parma, Not set
Research Site, Piacenza, Not set
Research Site, Torino, Not set
Research Site, Torrette, Not set
Research Site, Verona, Not set
Research Site, Ashikaga, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chiba-shi, Not set
Research Site, Chiba-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Kamakura, Not set
Research Site, Kasugai-shi, Not set
Research Site, Kitakyushu-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Matsumoto-shi, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Nagoya, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Toyota-Shi, Not set
Research Site, Urayasu-shi, Not set
Research Site, Anyang-si, Not set
Research Site, Busan, Not set
Research Site, Deagu, Not set
Research Site, Gwangju, Not set
Research Site, Gyeonggi-do, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Ipoh, Not set
Research Site, Johor Bahru, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Seremban, Not set
Research Site, Taiping, Not set
Research Site, Chihuahua, Not set
Research Site, Culiacan, Not set
Research Site, Guadalajara, Not set
Research Site, Juriquilla, Not set
Research Site, Mexico, Not set
Research Site, Zapopan, Not set
Research Site, Amsterdam, Not set
Research Site, Groningen, Not set
Research Site, Nijmegen, Not set
Research Site, Rotterdam, Not set
Research Site, Białystok, Not set
Research Site, Białystok, Not set
Research Site, Kraków, Not set
Research Site, Lublin, Not set
Research Site, Olsztyn, Not set
Research Site, Poznań, Not set
Research Site, Szczecin, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, Braga, Not set
Research Site, Funchal, Not set
Research Site, Lisbon, Not set
Research Site, Porto, Not set
Research Site, Torres Novas, Not set
Research Site, Bucureşti, Not set
Research Site, Cluj Napoca, Not set
Research Site, Timisoara, Not set
Research Site, Dammam, Not set
Research Site, Jeddah, Not set
Research Site, Riyadh, Not set
Research Site, Riyadh, Not set
Research Site, Riyadh, Not set
Research Site, Riyadh, Not set
Research Site, Banská Bystrica, Not set
Research Site, Bratislava, Not set
Research Site, Košice, Not set
Research Site, Martin, Not set
Research Site, A Coruña, Not set
Research Site, Alcalá de Henares, Not set
Research Site, Lérida, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Murcia, Not set
Research Site, Málaga, Not set
Research Site, Oviedo, Not set
Research Site, Sant Joan Despí, Not set
Research Site, Sevilla, Not set
Research Site, Tarragona, Not set
Research Site, Valencia, Not set
Research Site, Zaragoza, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, New Taipei City, Not set
Research Site, New Taipei, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Chaingmai, Not set
Research Site, Khlong Luang, Not set
Research Site, Khon Kaen, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Bursa, Not set
Research Site, İstanbul, Not set
Research Site, İstanbul, Not set
Research Site, Kahramanmaras, Not set
Research Site, Kayseri, Not set
Research Site, Kocaeli, Not set
Research Site, Konya, Not set
Research Site, Pamukkale, Not set
Research Site, Cambridge, Not set
Research Site, Doncaster, Not set
Research Site, Dundee, Not set
Research Site, Leicester, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Research Site, Reading, Not set
Research Site, Salford, Not set
Research Site, Stevenage, Not set
Conditions: Immunoglobulin A Nephropathy, IgAN
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Recruiting
The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, and irinotecan hydrochloride (FOLFIRI) versus cetuximab and mFOLFOX6 or FOLFIRI in adult participants with Kirsten rat sarcoma viral oncogene homolog (KRAS)/ Neuroblastoma R... Read More
The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, and irinotecan hydrochloride (FOLFIRI) versus cetuximab and mFOLFOX6 or FOLFIRI in adult participants with Kirsten rat sarcoma viral oncogene homolog (KRAS)/ Neuroblastoma RAS viral oncogene homolog (NRAS) and v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) wild type (WT) unresectable or metastatic left-sided colorectal cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona +221 locations
Banner MD Anderson Cancer Center, Gilbert, Arizona
St. Bernard's Medical Center, Jonesboro, Arkansas
CBCC Global Research, Bakersfield, California
Los Angeles Cancer Network, Glendale, California
Cancer and Blood Specialty Clinic, Los Alamitos, California
USC Norris Comprehensive Cancer Center, Los Angeles, California
UCLA, Santa Monica, California
Providence Medical Foundation, Santa Rosa, California
Torrance Memorial Physicians Network, Torrance, California
Rocky Mountain Cancer Centers, Denver, Colorado
Yale University School Of Medicine, New Haven, Connecticut
Georgetown Univ Medical Center Lombardi Cancer Center, Washington, District of Columbia
Florida Cancer Specialists South, Fort Myers, Florida
AdventHealth Medical Group Oncology and Hematology at Orlando, Orlando, Florida
Florida Cancer Specialists North Region, Saint Petersburg, Florida
Florida Cancer Specialists East, West Palm Beach, Florida
Grady Memorial Hospital, Atlanta, Georgia
Winship Cancer Institute Emory University, Atlanta, Georgia
Fort Wayne Medical Oncology & Hematology, Fort Wayne, Indiana
Ochsner Clinic Foundation, New Orleans, Louisiana
MedStar Franklin Square Medical Center, Baltimore, Maryland
VA Ann Arbor Healthcare System, Ann Arbor, Michigan
University of Michigan, Ann Arbor, Michigan
Henry Ford Hospital, Detroit, Michigan
Hattiesburg Clinic, Hattiesburg, Mississippi
Washington University School Of Medicine, Saint Louis, Missouri
Nebraska Cancer Specialists Midwest Cancer Center, Omaha, Nebraska
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
Astera Cancer Care, East Brunswick, New Jersey
Rutgers Cancer Institute, New Brunswick, New Jersey
University of New Mexico Cancer Center, Albuquerque, New Mexico
Montefiore Einstein Comprehensive Cancer Center, Bronx, New York
Perlmutter Cancer Center at NYU Long Island, Mineola, New York
Mount Sinai, New York, New York
Mount Sinai West, New York, New York
NYU Langone Medical Center NYU Hematology Associates, New York, New York
Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York, New York
New York Cancer and Blood Specialists, Shirley, New York
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
University Hospitals Cleveland Medical Center, Cleveland, Ohio
Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland, Ohio
Taussig Cancer Insititute Cleveland Clinic, Cleveland, Ohio
Cleveland Clinic Cancer Center Independence Family Health Center, Independence, Ohio
Cleveland Clinic Cancer Center Mansfield, Mansfield, Ohio
Cleveland Clinic Cancer Center Hillcrest Hospital, Mayfield Heights, Ohio
Cleveland Clinic Cancer Centers Sandusky, Sandusky, Ohio
Cleveland Clinic Cancer Center Strongsville, Strongsville, Ohio
Cleveland Clinic Cancer Center South Pointe Hospital, Warrensville Heights, Ohio
Wooster Milltown Specialty and Surgery Center, Wooster, Ohio
Thomas Jefferson University, Philadelphia, Pennsylvania
Fox Chase Cancer Center, Philadelphia, Pennsylvania
University Of Pittsburgh Medical Center UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
SCRI Oncology Partners, Nashville, Tennessee
Texas Oncology West Texas, Abilene, Texas
Texas Oncology DFW, Dallas, Texas
MD Anderson Cancer Center, Houston, Texas
Texas Oncology - San Antonio, San Antonio, Texas
Baylor Scott and White Health, Temple, Texas
Virginia Cancer Specialists, Arlington, Virginia
Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax, Virginia
VCU Massey Comprehensive Cancer Center, Richmond, Virginia
Swedish Cancer Institute, Edmonds, Washington
Swedish Cancer Institute, Issaquah, Washington
Swedish Cancer Institute, Seattle, Washington
William S. Middleton Memorial VA, Madison, Wisconsin
Institut Jules Bordet, Anderlecht, Not set
Universitair Ziekenhuis Antwerpen, Edegem, Not set
AZ Maria Middelares, Gent, Not set
Hopital de Jolimont, Haine Saint Paul La Louviere, Not set
Az Groeninge, Kortrijk, Not set
Universitair Ziekenhuis Leuven, Leuven, Not set
Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman, Liege, Not set
Fundacao Pio XII, Barretos, Not set
Fundacao Universidade de Caxias do Sul, Caxias do Sul, Not set
Fundacao Doutor Amaral Carvalho, Jau, Not set
Hospital Nossa Senhora da Conceicao S A, Porto Alegre, Not set
Hospital Santa Izabel Santa Casa de Misericordia da Bahia, Salvador, Not set
Clinica de Hematologia e Oncologia Viver Ltda, Santa Maria, Not set
Fundacao Faculdade Regional De Medicina S Jose Rio Preto Hospital De Base, Sao Jose do Rio Preto, Not set
Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Not set
Fundacao Antonio Prudente A C Camargo Cancer Center, Sao Paulo, Not set
Associacao Feminina de Educacao e Combate ao Cancer Hospital Santa Rita de Cassia, Vitoria, Not set
Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta
Ottawa Hospital, Ottawa, Ontario
Princess Margaret Cancer Centre, Toronto, Ontario
Centre de Recherche du CHUM, Montreal, Quebec
Peking University First Hospital, Beijing, Not set
Beijing Friendship Hospital Capital Medical University, Beijing, Not set
Beijing Cancer Hospital, Beijing, Not set
Peking University Third Hospital, Beijing, Not set
The First Bethune Hospital of Jilin University, Changchun, Not set
Hunan Cancer hospital, Changsha, Not set
Sun Yat Sen University Cancer Center, Guangzhou, Not set
The Sixth Affiliated Hospital Sun Yat sen University, Guangzhou, Not set
Guangdong Provincial People's Hospital, Guangzhou, Not set
The First Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, Not set
The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Harbin medical university cancer hospital, Harbin, Not set
Huizhou Central People's Hospital, Huizhou, Not set
The First Affiliated Hospital of NanChang University, Nanchang, Not set
Fudan University Shanghai Cancer Center, Shanghai, Not set
Liaoning Cancer Hospital and Institute, Shenyang, Not set
Peking University Shenzhen Hospital, Shenzhen, Not set
West China Hospital of Sichuan University, Sichuan, Not set
First Hospital of Shanxi Medical University, Taiyuan, Not set
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Not set
Hubei Cancer Hospital, Wuhan, Not set
Institut Sainte Catherine, Avignon Cedex 9, Not set
Hopital Claude Huriez, Lille, Not set
Hopital Prive Jean Mermoz, Lyon, Not set
Institut du Cancer de Montpellier, Montpellier, Not set
CHU Nantes, Nantes Cedex 1, Not set
Hopital Saint Antoine, Paris, Not set
Hopital Haut Leveque, Pessac, Not set
CHU De Poitiers, Poitiers Cedex, Not set
Gustave Roussy, Villejuif, Not set
Charite Universitatsmedizin Berlin Campus Virchow Klinikum, Berlin, Not set
Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Not set
Essen University Hospital, Essen, Not set
Krankenhaus NorthWest, Frankfurt am Main, Not set
Praxis fur interdisziplinare Onkologie & Hamatologie GbR, Freiburg, Not set
Asklepios Klinik Altona, Hamburg, Not set
National Center for Tumor Diseases NCT, Heidelberg, Not set
Universitatsmedizin der Johannes Gutenberg Universitat Mainz, Mainz, Not set
Klinikum der Universitaet Muenchen, Munich, Not set
Universitatsklinikum Ulm, Ulm, Not set
Semmelweis Egyetem, Budapest, Not set
Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger, Not set
Pecsi Tudomanyegyetem, Pecs, Not set
Szegedi Tudomanyegyetem, Szeged, Not set
Rajiv Gandhi Cancer Institute and Research Centre, Delhi, Not set
B P Poddar Hospital and Medical research Limited, Kolkata, Not set
Tata Memorial Hospital, Mumbai, Not set
Deenanath Mangeshkar Hospital and Research Centre, Pune, Not set
Mahamana Pandit Madan Mohan Malviya Cancer Centre, Varanasi, Not set
Yitzhak Shamir Medical Center, Beer Yaakov, Not set
Rambam Medical Center, Haifa, Not set
Hadassah University Hospita Ein Kerem, Jerusalem, Not set
Rabin Medical Center, Petah Tikva, Not set
Sheba Medical Center, Ramat Gan, Not set
Tel Aviv Sourasky Medical Center, Tel Aviv Yafo, Not set
Assuta MC, Tel Aviv Yafo, Not set
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Not set
Istituto Dei Tumori Di Milano, Milano, Not set
Istituto Oncologico Veneto - IRCCS, Padova, Not set
Azienda Ospedaliero Universitaria Pisana, Pisa, Not set
Istituto Clinico Humanitas, Rozzano, Not set
Chiba Cancer Center, Chiba, Not set
National Cancer Center Hospital, Chuo Ku, Not set
National Cancer Center Hospital East, Kashiwa, Not set
Aichi Cancer Center, Nagoya Shi, Not set
Osaka International Cancer Institute, Osaka City, Not set
National Hospital Organization Osaka National Hospital, Osaka-Shi, Not set
Shizuoka Cancer Center, Shizuoka, Not set
The University of Osaka Hospital, Suita City, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Kyungpook National University Chilgok Hospital, Daegu, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
The Catholic University of Korea Seoul St Marys Hospital, Seoul, Not set
Hospital Canselor Tuanku Muhriz UKM, Cheras, Not set
Hospital Pulau Pinang, Georgetown, Not set
Hospital Raja Permaisuri Bainun, Ipoh, Not set
Hospital Kuala Lumpur, Kuala Lumpur, Not set
University Malaya Medical Centre, Kuala Lumpur, Not set
Hospital Umum Sarawak, Kuching, Not set
National Cancer Institute, Putrajaya, Not set
Meander Medisch Centrum, Amersfoort, Not set
Antoni van Leeuwenhoek, Amsterdam, Not set
Radboud University Medical Center, Nijmegen, Not set
Erasmus MC, Rotterdam, Not set
Elisabeth-TweeSteden Ziekenhuis, Tilburg, Not set
UMC Utrecht, Utrecht, Not set
Wojewodzki Szpital Specjalistyczny, Biala Podlaska, Not set
Bialostockie Centrum Onkologii im Marii Sklodowskiej Curie w Bialymstoku, Bialystok, Not set
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, Not set
Uniwersyteckie Centrum Kliniczne, Gdansk, Not set
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut BadawczyOddz w Gliwicach, Gliwice, Not set
Instytut Centrum Zdrowia Matki Polki, Lodz, Not set
SPZOZ Ministerstwa Spraw Wewnetrznych z Warminsko Mazurskim Centrum Onkologii w Olsztynie, Olsztyn, Not set
SPZOZ Opolskie Centrum Onkologii im. Prof. Tadeusza Koszarowskiego, Opole, Not set
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warszawa, Not set
Pan American Center for Oncology Trials LLC, Barrio Monacillos, Not set
Hosp. de La Santa Creu I Sant Pau, Barcelona, Not set
Hosp Univ Vall D Hebron, Barcelona, Not set
Hosp. Gral. Univ. Gregorio Maranon, Madrid, Not set
Hosp. Univ. Ramon Y Cajal, Madrid, Not set
Hosp. Univ. 12 de Octubre, Madrid, Not set
Clinica Univ. de Navarra, Pamplona, Not set
Hosp. Virgen Del Rocio, Sevilla, Not set
Hosp. Clinico Univ. de Valencia, Valencia, Not set
Sahlgrenska University Hospital, Goteborg, Not set
Skanes universitetssjukhus, Lund, Not set
Sodersjukhuset, Stockholm, Not set
Karolinska Universitetssjukhuset, Stockholm, Not set
Uppsala University, Uppsala, Not set
Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Linkou Chang Gung Memorial Hospital, Taoyuan, Not set
Adana City Hospital, Adana, Not set
Gulhane Egitim ve Arastirma Hastanesi, Ankara, Not set
Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Not set
Gazi University Hospital, Ankara, Not set
Ankara Bilkent Sehir Hastanesi, Ankara, Not set
Bakirkoy Training and Research Hospital, Istanbul, Not set
Marmara University Pendik Training Hospital, İstanbul, Not set
Necmettin Erbakan University Meram Medical Faculty, Konya, Not set
Sakarya University Training and Research Hospital, Sakarya, Not set
Birmingham Heartlands Hospital, Birmingham, Not set
Addenbrooke's Hospital, Cambridge, Not set
Western General Hospital, Edinburgh, Not set
Castle Hill Hospital, Hull, Not set
St James University Hospital, Leeds, Not set
St Bartholomew's Hospital, London, Not set
University College Hospital, London, Not set
Mount Vernon Cancer Centre, Northwood, Not set
Royal Marsden Hospital (Sutton), Sutton, Not set
Conditions: Colorectal Neoplasms
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Recruiting
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: St. Bernard's Medical Center, Jonesboro, Arkansas +78 locations
St. Bernard's Medical Center, Jonesboro, Arkansas
PIH Health Good Samaritan Hospital, Los Angeles, California
Cedars - Sinai Medical Center, Los Angeles, California
Ronald Reagan UCLA Medical Center, Los Angeles, California
Sutter Medical Center, Sacramento, Sacramento, California
Adventist Health St Helena Hospital, Saint Helena, California
Yale University School of Medicine, New Haven, Connecticut
Christiana Hospital, Newport, Delaware
Washington Hospital Center, Washington, District of Columbia
Palm Beach Heart & Vascular, LLC, Boynton Beach, Florida
Tallahassee Memorial Hospital, Tallahassee, Florida
Emory University Hospital, Atlanta, Georgia
South Georgia Medical Center, Valdosta, Georgia
Rush University, Chicago, Illinois
St. John's Hospital/ Prairie Education and Research Cooperative, Springfield, Illinois
St. Joseph Hospital/Dupont Hospital, Fort Wayne, Indiana
Ascension St. Vincent's Hospital, Indianapolis, Indiana
CIS Clinical Research Corporation, Houma, Louisiana
Ochsner Clinic Foundation, Kenner, Louisiana
Cardiovascular Institute of the South, Lafayette, Louisiana
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Mercy Hospital (Allina Health), Coon Rapids, Minnesota
North Mississippi Medical Center, Tupelo, Mississippi
Deborah Heart & Lung Center, Brown Mills, New Jersey
Hackensack University Medical Center, Hackensack, New Jersey
Newark Beth Israel Medical Center, Newark, New Jersey
Buffalo General Hospital, Buffalo, New York
North Shore University Hospital/Northwell Health, Manhasset, New York
New York University Medical Center, New York, New York
Columbia University, New York, New York
Mount Sinai, New York, New York
Memorial Sloan Kettering Hospital, New York, New York
Weill Cornell Medicine/New York-Presbyterian Hospital, New York, New York
Duke University Medical Center, Durham, North Carolina
Rex UNC Health (NC Heart and Vascular Research, LLC), Raleigh, North Carolina
University Hospitals of Cleveland, Cleveland, Ohio
Cleveland Clinic Foundation, Cleveland, Ohio
Premier Cardiovascular Institute, Dayton, Ohio
Ascension St. John Clinical Research Institute, Tulsa, Oklahoma
Pinnacle Health Cardiovascular Institute, Harrisburg, Pennsylvania
Hospital University of Pennsylvania, Philadelphia, Pennsylvania
Thomas Jefferson University, Philadelphia, Pennsylvania
The Miriam Hospital, Providence, Rhode Island
Medical University of South Carolina, Charleston, South Carolina
Monument Health Rapid City Hospital, Inc., Rapid City, South Dakota
Seton Medical Center, Austin, Texas
The University of Texas, Southwestern Medical Center, Dallas, Texas
Baylor College of Medicine, Houston, Texas
Texas Tech University Health Sciences Center, Lubbock, Texas
HeartPlace P.A., Plano, Texas
Inova Fairfax Hospital, Fairfax, Virginia
UW Medicine - Harborview Medical Center, Seattle, Washington
Royal Perth Hospital, Perth, Western Australia
Royal North Shore Hospital, St. Leonards, Not set
Medizinische Univ.-Kliniken Graz, Graz, Not set
Peter Lougheed Centre-Hospital, Calgary, Alberta
CHUS - Hotel Dieu, Sherbrooke, Quebec
Beijing Anzhen Hospital of the Capital University of Medical Sciences, Chaoyang, Beijing
China-Japan Friendship Hospital, Chaoyang, Beijing
Xuanwu Hospital Capital Medical University, Xicheng, Beijing
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing
Zhongshan University No.1 Hospital, Guangzhou, Guangdong
Affiliated Hospital of Medical College Qingdao University, Qingdao, Shandong
Shanghai Ninth People's Hospital - Shanghai Jiaotong University School of Medicine, Huangpu, Shanghai
Shanghai Changhai Hospital, Yangpu, Shanghai
Shanxi Bethune Hospital, Taiyuan, Shanxi
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shanxi
Shanghai Zhongshan Hospital, Shanghai, Xuhui District
Hospital Marie Lannelongue, Le Plessis-Robinson, Not set
Hospital Paris Saint Joseph, Paris, Not set
Fürst Stirum Klinik Bruchsal Hospital, Bruchsal, Not set
University Clinic Essen-Hospital, Essen, Not set
Klinikum der Ludwig-Maximilians-Universitat, München, Not set
Uniwersyteckim Szpitalem Klinicznym w Poznaniu, Poznań, Not set
Corporacio Sanitaria Parc Taulí, Barcelona, Sabadell, Not set
China Medical University Hospital, Taichung, Not set
National Taiwan University Hospital, Taipei City, Not set
Siriraj Hospital Department of Surgery, Bangkok, Not set
Prince of Songkla University, Hat Yai, Not set
Conditions: Peripheral Vascular Diseases
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Recruiting
The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (with nodal involvement \[N2\]) non-small cell lung cancer (NSCLC). The primary hypothesis is that intismeran autogene plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS) as assessed by the investigator.
The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (with nodal involvement \[N2\]) non-small cell lung cancer (NSCLC). The primary hypothesis is that intismeran autogene plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS) as assessed by the investigator. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: Alaska Oncology and Hematology ( Site 0039), Anchorage, Alaska +198 locations
Alaska Oncology and Hematology ( Site 0039), Anchorage, Alaska
The University of Arizona Cancer Center - North Campus ( Site 0071), Tucson, Arizona
YUMA REGIONAL MEDICAL CENTER CANCER CENTER ( Site 0020), Yuma, Arizona
UCLA Clinical & Translational Research Center (CTRC) ( Site 0059), Los Angeles, California
St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0074), Orange, California
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0030), Orange, California
UCHealth Memorial Hospital-Heme Onc ( Site 0052), Colorado Springs, Colorado
Mayo Clinic Florida ( Site 4043), Jacksonville, Florida
Mid Florida Hematology and Oncology Center ( Site 0014), Orange City, Florida
AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0013), Orlando, Florida
Moffitt Cancer Center ( Site 0078), Tampa, Florida
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0012), Marietta, Georgia
Southeastern Regional Medical Center ( Site 0098), Newnan, Georgia
Beacon Cancer Care ( Site 0044), Post Falls, Idaho
University of Iowa-Holden Comprehensive Cancer Center ( Site 0062), Iowa City, Iowa
Saint Elizabeth Healthcare ( Site 0092), Edgewood, Kentucky
The University of Louisville, James Graham Brown Cancer Center ( Site 0037), Louisville, Kentucky
University of Michigan Clinical Trials Office ( Site 0058), Ann Arbor, Michigan
Cancer and Hematology Centers of Western Michigan ( Site 4003), Grand Rapids, Michigan
St. Vincent Frontier Cancer Center ( Site 0043), Billings, Montana
NHO Revive Research Institute, LLC ( Site 4009), Lincoln, Nebraska
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0036), Hackensack, New Jersey
Atlantic Health Morristown Medical Center ( Site 4018), Morristown, New Jersey
New York Oncology Hematology, P.C. ( Site 4012), Albany, New York
Montefiore Medical Center- Montefiore Medical Park-Oncology ( Site 0080), Bronx, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island-Clinical Research Department ( Site 0095), Mineola, New York
Laura and Isaac Perlmutter Cancer Center ( Site 0010), New York, New York
Icahn School of Medicine at Mount Sinai ( Site 0034), New York, New York
Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 0054), New York, New York
Memorial Sloan Kettering Cancer Center ( Site 0029), New York, New York
Stony Brook University-Cancer Center ( Site 0072), Stony Brook, New York
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0063), Fargo, North Dakota
Altru Health System ( Site 0040), Grand Forks, North Dakota
Summa Health ( Site 4011), Akron, Ohio
University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0028), Cincinnati, Ohio
University Hospitals Cleveland Medical Center ( Site 0023), Cleveland, Ohio
OSU Brain and Spine Hospital ( Site 0016), Columbus, Ohio
Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0082), Corvallis, Oregon
Thomas Jefferson University - Clinical Research Institute ( Site 0006), Philadelphia, Pennsylvania
Medical University of South Carolina-Hollings Cancer Center ( Site 0050), Charleston, South Carolina
Sanford Cancer Center ( Site 0075), Sioux Falls, South Dakota
Thompson Cancer Survival Center ( Site 0097), Knoxville, Tennessee
One Oncology - Tennessee Oncology ( Site 4019), Nashville, Tennessee
SCRI Oncology Partners ( Site 7001), Nashville, Tennessee
UT Southwestern Medical Center ( Site 0061), Dallas, Texas
Inova Schar Cancer Institute ( Site 0003), Fairfax, Virginia
Swedish Medical Center-Swedish Cancer Institute ( Site 0088), Seattle, Washington
Fred Hutchinson Cancer Center ( Site 0002), Seattle, Washington
Edwards Comprehensive Cancer Center ( Site 4015), Huntington, West Virginia
Clinica Adventista Belgrano-Oncology ( Site 2901), Caba., Buenos Aires
Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2912), Ciudad Autonoma de Buenos Aires, Buenos Aires
Instituto Alexander Fleming ( Site 2911), Ciudad Autónoma de Buenos Aires, Buenos Aires
Instituto de Investigaciones Clínicas Mar del Plata ( Site 2908), Mar del Plata, Buenos Aires
Fundacion Estudios Clinicos-Oncology ( Site 2907), Rosario, Santa Fe
Sanatorio Parque ( Site 2904), Rosario, Santa Fe
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0203), Melbourne, Victoria
St Vincent's Hospital-Oncology Clinical Trials ( Site 0202), Melbourne, Victoria
One Clinical Research ( Site 0200), Nedlands, Western Australia
Antwerp University Hospital-Thoracic Oncology ( Site 0603), Edegem, Antwerpen
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 0602), Yvoir, Namur
AZORG Campus Aalst-Moorselbaan ( Site 0604), Aalst, Oost-Vlaanderen
VITAZ ( Site 0600), Sint-Niklaas, Oost-Vlaanderen
CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 3007), Fortaleza, Ceara
Liga Norte Riograndense Contra o Câncer ( Site 3001), Natal., Rio Grande Do Norte
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 3003), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição ( Site 3002), Porto Alegre, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 3004), Barretos, Sao Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 3013), São José do Rio Preto, Sao Paulo
Instituto Nacional de Câncer - INCA ( Site 3000), Rio de Janeiro, Not set
Hospital Samaritano De Sao Paulo ( Site 3006), Sao Paulo, Not set
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 3005), Sao Paulo, Not set
Cross Cancer Institute ( Site 0105), Edmonton, Alberta
William Osler Health System ( Site 0101), Brampton, Ontario
Princess Margaret Cancer Centre ( Site 0102), Toronto, Ontario
Centre Hospitalier de l'Université de Montréal ( Site 0104), Montréal, Quebec
McGill University Health Centre ( Site 0100), Montréal, Quebec
Orlandi Oncologia-Oncology ( Site 3102), Santiago, Region M. De Santiago
FALP-UIDO ( Site 3100), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile ( Site 3104), Santiago, Region M. De Santiago
Bradfordhill-Clinical Area ( Site 3103), Santiago, Region M. De Santiago
ONCOCENTRO APYS ( Site 3105), Viña del Mar, Valparaiso
CIMCA ( Site 3300), San José, San Jose
ICIMED ( Site 3301), San Jose, Not set
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0700), Brno, Brno-mesto
Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni odd ( Site 0702), Ostrava, Ostrava Mesto
Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 0701), Olomouc, Not set
Vseobecna fakultni nemocnice v Praze ( Site 0703), Praha 2, Not set
Rigshospitalet ( Site 0801), Copenhagen, Hovedstaden
Odense Universitetshospital ( Site 0800), Odense C, Syddanmark
North Estonia Medical Centre Foundation-Chemotherapy ( Site 0901), Tallinn, Harjumaa
Tartu University Hospital-Radiotherapy and oncology ( Site 0900), Tartu, Tartumaa
Tampereen yliopistollinen sairaala-Oncology ( Site 1001), Tampere, Pirkanmaa
Vaasan Keskussairaala-Department of Clinical Oncology ( Site 1004), Vaasa, Pohjanmaa
Oulun yliopistollinen sairaala-Oncology and Hematology ( Site 1003), Oulu, Pohjois-Pohjanmaa
Turku University Hospital-The Department of Pulmonary Medicine ( Site 1000), Turku, Varsinais-Suomi
Nouvel Hôpital Civil (NHC)-Service de pneumologie ( Site 1100), Strasbourg, Alsace
CHU Bordeaux Haut-Leveque ( Site 1106), Pessac, Aquitaine
Assistance Publique Hôpitaux de Marseille - Hôpital Nord ( Site 1108), Marseille, Bouches-du-Rhone
Centre Hospitalier Universitaire de Caen - Hôpital Côte de Nacre ( Site 1107), Caen, Calvados
Hôpital Arnaud de Villeneuve - CHU Montpellier ( Site 1102), Montpellier, Herault
Institut de Cancérologie de l'Ouest ( Site 1101), ANGERS cedex 02, Maine-et-Loire
CHU GABRIEL MONTPIED ( Site 1105), Clermont-Ferrand, Puy-de-Dome
Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 1104), Paris, Not set
Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1201), Esslingen, Baden-Wurttemberg
Asklepios Klinik Gauting GmbH-Oncology ( Site 1209), Gauting, Bayern
Klinikverbund Allgäu gGmbH ( Site 1205), Kempten, Bayern
Universitaetsklinikum Regensburg ( Site 1204), Regensburg, Bayern
Augusta-Kranken-Anstalt ( Site 1213), Bochum, Nordrhein-Westfalen
Gemeinschaftspraxis für Hämatologie und Onkologie Münster ( Site 1202), Münster, Nordrhein-Westfalen
Brüderkrankenhaus St. Josef Paderborn-Klinik für Hämatologie und Onkologie ( Site 1214), Paderborn, Nordrhein-Westfalen
SRH Wald-Klinikum Gera-Lungenkrebszentrum ( Site 1200), Gera, Thuringen
Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 1208), Berlin, Not set
Errikos Dunant Hospital Center-Fourth Department of Oncology and Clinical Trials Unit ( Site 1301), Athens, Attiki
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1300), Athens, Attiki
European Interbalkan Medical Center-Oncology Department ( Site 1302), Thessaloniki, Not set
Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 1401), Kecskemét, Bacs-Kiskun
Pécsi Tudományegyetem Klinikai Központ-Onkoterápiás Intézet ( Site 1402), Pecs, Baranya
Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz - Pulmonologia Osztaly ( Site 1404), Gyor, Gyor-Moson-Sopron
Reformatus Pulmonologiai Centrum ( Site 1405), Törökbálint, Pest
Somogy Varmegyei Kaposi Mor Oktato Korhaz -Onkologiai Kozpont ( Site 1407), Kaposvár, Somogy
Tallaght University Hospital ( Site 3903), Dublin, Not set
CRO-IRCCS-Clinical Oncology ( Site 1510), Aviano, Friuli-Venezia Giulia
P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers-Oncology Department ( Site 1506), Udine, Friuli-Venezia Giulia
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1504), Milan, Lombardia
ASST Grande Ospedale Metropolitano Niguarda-Oncologia Falck ( Site 1511), Milan, Milano
A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1508), Naples, Napoli
Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1507), Bari, Puglia
POLICLINICO "G. RODOLICO"-UOC Oncologia Medica ( Site 1503), Catania, Sicilia
AO Santa Maria della Misericordia-Oncology Department ( Site 1501), Perugia, Umbria
Azienda Ospedaliera Santa Croce e Carle ( Site 1500), Cuneo, Not set
Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 1502), Novara, Not set
National Cancer Center Hospital East ( Site 3800), Kashiwa, Chiba
St. Marianna University Hospital ( Site 3802), Kawasaki, Kanagawa
Kanagawa Cancer Center ( Site 3801), Yokohama, Kanagawa
Kansai Medical University Hospital ( Site 3806), Hirakata, Osaka
Kindai University Hospital ( Site 3803), Osakasayama, Osaka
Hiroshima University Hospital ( Site 3804), Hiroshima, Not set
Chungbuk National University Hospital-Internal medicine ( Site 0402), Cheongju-si, Chungbuk
National Cancer Center-Lung Cancer Center ( Site 0403), Goyang-si, Kyonggi-do
Seoul National University Bundang Hospital-Medical Oncology ( Site 0404), Seongnam, Kyonggi-do
The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 0406), Suwon-si, Kyonggi-do
Keimyung University Dongsan Hospital CRC room 1 ( Site 0407), Daegu, Taegu-Kwangyokshi
Seoul National University Hospital ( Site 0400), Seoul, Not set
Asan Medical Center-Department of Oncology ( Site 0405), Seoul, Not set
Samsung Medical Center ( Site 0401), Seoul, Not set
RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia ( Site 1600), Riga, Not set
Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 1701), Kaunas, Kauno Apskritis
National Cancer Institute-Department of Thoracic Surgery and Oncology ( Site 1700), Vilnius, Vilniaus Miestas
University Malaya Medical Centre ( Site 3502), Lembah Pantai, Kuala Lumpur
National Cancer Institute-Radiotherapy and Oncology ( Site 3506), Putrajaya, Kuala Lumpur
Hospital Tengku Ampuan Afzan ( Site 3504), Kuantan, Pahang
Hospital Pulau Pinang ( Site 3505), George Town, Pulau Pinang
Sarawak General Hospital ( Site 3500), Kuching, Sarawak
CIO - Centro de Inmuno-Oncología de Occidente ( Site 3403), Guadalajara, Jalisco
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 3408), Monterrey, Nuevo Leon
Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 3402), Chihuahua, Not set
Mediadvance Clinical ( Site 3404), Chihuahua, Not set
Oaxaca Site Management Organization S.C. ( Site 3407), Oaxaca, Not set
Centro de Investigacion Clinica de Oaxaca ( Site 3401), Oaxaca, Not set
New Zealand Clinical Research (Christchurch) ( Site 0300), Christchurch, Canterbury
Harbour Cancer & Wellness ( Site 0301), Auckland, Not set
Akershus Universitetssykehus-Avdeling for lungesykdommer ( Site 1900), Lørenskog, Akershus
Drammen Sykehus, Vestre Viken HF ( Site 1903), Drammen, Buskerud
Stavanger Universitetssykehus ( Site 1901), Stavanger, Rogaland
Metro Davao Medical and Research Center ( Site 3602), Davao City, Davao Del Sur
ST. LUKE'S MEDICAL CENTER ( Site 3606), Quezon City, National Capital Region
CARDINAL SANTOS MEDICAL CENTER-Research Room ( Site 3601), San Juan City, Metro Manila, National Capital Region
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2003), Bydgoszcz, Kujawsko-pomorskie
Krakowski Szpital Specjalistyczny im. Jana Pawła II-Oddział Kliniczny Chirurgii Klatki Piersiowej i ( Site 2011), Krakow, Malopolskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2001), Przemysl, Podkarpackie
Bialostockie Centrum Onkologii ( Site 2005), Bialystok, Podlaskie
Uniwersyteckie Centrum Kliniczne ( Site 2013), Gdansk, Pomorskie
Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemioterapii ( Site 2008), Olsztyn, Warminsko-mazurskie
Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 2002), Poznan, Wielkopolskie
Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2703), Lisbon, Lisboa
Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2702), Porto, Not set
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica ( Site 2202), Banska Bystrica, Banskobystricky Kraj
Univerzitná nemocnica Bratislava - Nemocnica Ružinov ( Site 2201), Bratislava, Bratislavsky Kraj
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2401), L'Hospitalet de Llobregat, Barcelona
HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Medical Oncology ( Site 2403), Majadahonda, Madrid, Comunidad De
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2402), Pozuelo de Alarcon, Madrid
Hospital Quirón Málaga ( Site 2405), Málaga, Malaga
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2400), Barcelona, Not set
Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2404), Sevilla, Not set
National Taiwan University Cancer Center (NTUCC) ( Site 0500), Taipei City, Taipei
Changhua Christian Hospital ( Site 0504), Changhua, Not set
National Taiwan University Hospital - Hsinchu branch ( Site 0501), Hsinchu, Not set
Taichung Veterans General Hospital-Chest ( Site 0503), Taichung, Not set
National Cheng Kung University Hospital-Clinical Trial Center ( Site 0505), Tainan, Not set
National Taiwan University Hospital-Oncology ( Site 0506), Taipei, Not set
Taipei Medical University Hospital ( Site 0502), Taipei, Not set
Medipol Mega Universite Hastanesi-oncology ( Site 2105), Stanbul, Istanbul
Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2107), Bornova, Izmir
Hacettepe Universite Hastaneleri-oncology hospital ( Site 2100), Ankara, Not set
Memorial Ankara Hastanesi-Medical Oncology ( Site 2103), Ankara, Not set
Liv Hospital Ankara-Oncology ( Site 2104), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 2101), Ankara, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2102), Istanbul, Not set
Conditions: Non-small Cell Lung Cancer
Collection of Tissue Samples for Cancer Research
Recruiting
Background:
-Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection of tissue specimens.
Objectives:
* To obtain samples from adult and pediatric patients for research purposes from tests and procedures that are done as required by the primary research protocol(s) to which a patient is enrolled or as part of their standard-of-care treatment.
* To obtain samples fo... Read More
Background:
-Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection of tissue specimens.
Objectives:
* To obtain samples from adult and pediatric patients for research purposes from tests and procedures that are done as required by the primary research protocol(s) to which a patient is enrolled or as part of their standard-of-care treatment.
* To obtain samples for research purposes from non-surgical procedures, such as percutaneous biopsies, performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol.
Eligibility:
-Adult patients (18 years of age and older) and pediatric patients (younger than 18 years of age) who are being evaluated for and/or treated for cancer at the NIH Clinical Center participating sites.
Design:
* This is a multicenter tissue procurement protocol with NCI as the coordinating center.
* For adult patients: specimens for research purposes, as outlined in this protocol, will be obtained from tests and procedures that are done as required by the primary research protocols to which a patient is enrolled or as part of their standard-of-care treatment. Non-surgical procedures, such as percutaneous biopsies, may also be performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Tissues and biological fluids to be procured may include but are not limited to blood, serum, urine, tumor tissue, normal tissue, pleural fluid, CSF, saliva, bronchial alveolar lavage (BAL), circulating tumor cells, hair follicles, and bone marrow. These specimens will be stored with unique identifiers and used to perform only those research studies that are outlined in this protocol.
* For pediatric patients: tumor biopsy/resection tissue used for pediatric preclinical model development will only be from tissue already being obtained as part of a procedure necessary for the patient s clinical care or as part of a primary research protocol; blood specimens will be collected as part of a blood collection already scheduled for the patient s clinical care or as part of the planned pre-procedure bloodwork; volumes collected will not exceed institutional research limits.
* Given the risks associated with any invasive procedure, such as tumor biopsy, the procedure will be discussed in detail with the patients and their parents/guardian (as indicated), including the side effects, prior to obtaining a separate consent for each procedure. A separate consent will not be signed prior to obtaining samples by minimally invasive measures, such as venipuncture.
* This study has two separate consent forms at the NIH Clinical Center: one for adult patients to donate specimens for ongoing research on assay development and studies of molecular pathways, and one for adult and age-appropriate pediatric patients to donate samples for the generation of preclinical models. The study also has consent form templates for adult and pediatric patients at participating sites to donate specimens to create preclinical models.
* Patients may remain on study for the duration of their consent or completion of the planned procedure, whichever comes first. Read Less
Gender:
ALL
Ages:
2 months and above
Trial Updated:
08/13/2025
Locations: UC Davis, Sacramento, California +16 locations
UC Davis, Sacramento, California
University of Colorado, Denver, Aurora, Colorado
Emory University, Atlanta, Georgia
Indiana University - Purdue, Indianapolis, Indiana
University of Iowa, Iowa City, Iowa
Johns Hopkins University, Baltimore, Maryland
National Institutes of Health Clinical Center, Bethesda, Maryland
University of Michigan Ann Arbor, Ann Arbor, Michigan
Washington University - St. Louis, Saint Louis, Missouri
Roswell Park Cancer Institute, Buffalo, New York
Ohio State University, Columbus, Ohio
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Medical University of South Carolina, Charleston, South Carolina
University of Utah, Salt Lake City, Utah
University of Virginia, Charlottesville, Charlottesville, Virginia
Fred Hutchinson, Seattle, Washington
Princess Margaret Hospital Cancer Centre, Toronto, Not set
Conditions: Neoplasms, Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Recruiting
Sodium zirconium cyclosilicate has been shown to be effective and safe in adults for the treatment of hyperkalaemia, and therefore it is expected to be beneficial in children. This study will evaluate the efficacy, safety and tolerability of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in children \<18 years of age. Approximately 140 participants will enter CP at approximately 46 sites in locations including but not limited to Europe and North America for this study. Treatme... Read More
Sodium zirconium cyclosilicate has been shown to be effective and safe in adults for the treatment of hyperkalaemia, and therefore it is expected to be beneficial in children. This study will evaluate the efficacy, safety and tolerability of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in children \<18 years of age. Approximately 140 participants will enter CP at approximately 46 sites in locations including but not limited to Europe and North America for this study. Treatment will include 3 phases: the CP, MP, and LTMP. Enrolment will start in 2 cohorts, ages 6 to \< 12 years and 12 to \< 18 years. After review of accumulated data, the independent Data Monitoring Committee (iDMC) will recommend whether to open enrolment in the ages 2 to \< 6 years cohort and later in the ages 0 to \< 2 years cohort. All eligible participants with hyperkalaemia will enter an open-label Correction Phase (CP) receiving a fixed dose of SZC three times daily (TID) for up to 3 days until normokalaemia is achieved. Within each age cohorts 2 to \< 18 years, initial participants will be allocated to the dose level (DL) based on body weight equivalent to an adult 5 g TID. After recommendation of higher DLs by the iDMC, subsequent participants may be allocated in the CP to on body weight equivalent to an adult 10 g TID and then potentially on body weight equivalent to an adult 15 g TID. All participants in the ages 0 to \< 2 years cohort will be assigned to the same DL which will be decided based on data from older age cohorts. Participants who successfully achieve normokalaemia in the CP will enter a 28-day open-label Maintenance Phase (MP), which will be initiated with once daily administration of the dose received TID in the CP. During MP, the Investigator is able to titrate the dose up or down in the range 2.5 g to 15 g body weight equivalent to maintain normokalaemia. For participants who, at the end of MP, are normokalaemic or hyperkalaemic without being on maximum dose, the MP is followed by the option to continue the study in a long term maintenance phase (LTMP) where the same titration regimen is used as in MP Read Less
Gender:
ALL
Ages:
Between 0 years and 18 years
Trial Updated:
08/13/2025
Locations: Research Site, Birmingham, Alabama +68 locations
Research Site, Birmingham, Alabama
Research Site, Atlanta, Georgia
Research Site, Baltimore, Maryland
Research Site, Grand Rapids, Michigan
Research Site, Saint Louis, Missouri
Research Site, Hackensack, New Jersey
Research Site, New York, New York
Research Site, Stony Brook, New York
Research Site, Charlotte, North Carolina
Research Site, Winston-Salem, North Carolina
Research Site, Akron, Ohio
Research Site, Cincinnati, Ohio
Research Site, Columbia, South Carolina
Research Site, Morgantown, West Virginia
Research Site, Campinas, Not set
Research Site, Sao Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Calgary, Alberta
Research Site, Edmonton, Alberta
Research Site, Vancouver, British Columbia
Research Site, Montreal, Quebec
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Hangzhou, Not set
Research Site, Hefei, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Berlin, Not set
Research Site, Essen, Not set
Research Site, Heidelberg, Not set
Research Site, Bhubaneshwar, Not set
Research Site, Gurgaon, Not set
Research Site, New Delhi, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Fuchu-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Kawasaki-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Matsumoto-shi, Not set
Research Site, Nakagami-gun, Not set
Research Site, Saitama-Shi, Not set
Research Site, Sendai-Shi, Not set
Research Site, Shizuoka-Shi, Not set
Research Site, Białystok, Not set
Research Site, Krakow, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, Bucuresti, Not set
Research Site, București, Not set
Research Site, Cluj-Napoca, Not set
Research Site, Targu Mures, Not set
Research Site, Timisoara, Not set
Research Site, Samara, Not set
Research Site, Esplugues de Llobregat, Not set
Research Site, Madrid, Not set
Research Site, Dnipropetrovsk, Not set
Research Site, Kharkiv Region, Not set
Research Site, Kyiv, Not set
Research Site, Odesa, Not set
Research Site, Sumy, Not set
Research Site, Zaporizhzhia, Not set
Research Site, Glasgow, Not set
Research Site, Hampshire, Not set
Research Site, Manchester, Not set
Research Site, Nottingham, Not set
Conditions: Hyperkalaemia
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Recruiting
The purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PGN-EDODM1 are for people with myotonic dystrophy type 1 (DM1) compared to placebo.
The purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PGN-EDODM1 are for people with myotonic dystrophy type 1 (DM1) compared to placebo. Read Less
Gender:
ALL
Ages:
Between 16 years and 60 years
Trial Updated:
08/13/2025
Locations: University of Calgary, Calgary, Alberta +5 locations
University of Calgary, Calgary, Alberta
Ottawa Hospital Research Institute (OHRI), Ottawa, Ontario
CIUSSS du Saguenay-Lac-Saint-Jean, Chicoutimi, Quebec
Montreal Neurological Institute, Montréal, Quebec
University College London Hospitals NHS Foundation Trust, London, UK
Newcastle Upon Tyne Hospitals, Newcastle Upon Tyne, Not set
Conditions: Myotonic Dystrophy 1
Lupus Landmark Study: A Prospective Registry and Biorepository
Recruiting
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN). Read Less
Gender:
ALL
Ages:
Between 18 years and 110 years
Trial Updated:
08/13/2025
Locations: University of Alabama at Birmingham, Birmingham, Alabama +20 locations
University of Alabama at Birmingham, Birmingham, Alabama
University of Arizona, Tucson, Arizona
Wallace Rheumatic Studies Center, Beverly Hills, California
University of Miami, Miami, Florida
Emory University, Atlanta, Georgia
University of Chicago, Chicago, Illinois
University of Massachusetts Memorial Health, Worcester, Massachusetts
Washington University, Saint Louis, Missouri
The Feinstein Institutes for Medical Research, Manhasset, New York
Columbia University Medical Center, New York, New York
Northwell Health, New York, New York
SUNY Upstate, Syracuse, New York
UNC Chapel Hill, Chapel Hill, North Carolina
The MetroHealth System, Cleveland, Ohio
Vanderbilt University Medical Center, Nashville, Tennessee
UT Southwestern Medical Center, Dallas, Texas
University of Calgary, Calgary, Alberta
University of Manitoba, Winnipeg, Manitoba
University Health Network/Toronto Western Hospital, Toronto, Ontario
McGill University Health Centre, Montréal, Quebec
CHU de Québec - Université Laval, Quebec City, Quebec
Conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
Recruiting
The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at Week 12, and that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the M... Read More
The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at Week 12, and that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at week 52. Study 2's primary hypothesis is that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at Week 12. Read Less
Gender:
ALL
Ages:
Between 16 years and 80 years
Trial Updated:
08/13/2025
Locations: Digestive Health Specialists ( Site 0135), Dothan, Alabama +450 locations
Digestive Health Specialists ( Site 0135), Dothan, Alabama
IMC-Gulf Coast Gastroenterology ( Site 0157), Fairhope, Alabama
Research Solutions of Arizona ( Site 3816), Litchfield Park, Arizona
One of a Kind Clinical Research Center ( Site 3852), Scottsdale, Arizona
GI Alliance - Sun City ( Site 0103), Sun City, Arizona
Clinnova Research ( Site 3803), Anaheim, California
Southern California Research Center ( Site 3828), Coronado, California
UCSD - Altman Clinical and Translational Research Institute (ACTRI) ( Site 0113), La Jolla, California
Cedars-Sinai Medical Center ( Site 0119), Los Angeles, California
University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 0172), Aurora, Colorado
Peak Gastroenterology Associates ( Site 0116), Colorado Springs, Colorado
South Denver Gastroenterology, PC ( Site 3849), Englewood, Colorado
Rocky Mountain Gastroenterology/Topography Health ( Site 3838), Littleton, Colorado
Connecticut Clinical Research Institute ( Site 0126), Bristol, Connecticut
Medical Research Center of Connecticut ( Site 0151), Hamden, Connecticut
Yale University School of Medicine-Digestive Disease ( Site 0163), New Haven, Connecticut
Emerson Clinical Research Institute ( Site 3820), Washington, District of Columbia
Gastroenterology Consultants of Clearwater ( Site 0152), Clearwater, Florida
University of Florida College of Medicine-Gastroenterology ( Site 3821), Gainesville, Florida
Nature Coast Clinical Research - Inverness ( Site 3806), Inverness, Florida
Central Florida Gastro Research ( Site 0124), Kissimmee, Florida
Research Associates of South Florida - Miami - Southwest 8th Street ( Site 3810), Miami, Florida
Orlando Health ( Site 0145), Orlando, Florida
USF Health ( Site 0169), Tampa, Florida
Emory University School of Medicine ( Site 3818), Atlanta, Georgia
Atlanta Gastroenterology Associates - Peachtree Dunwoody ( Site 0115), Atlanta, Georgia
Atlanta Center for Gastroenterology ( Site 0155), Decatur, Georgia
University of Chicago Medical Center ( Site 0134), Chicago, Illinois
GI Alliance - Glenview ( Site 0168), Glenview, Illinois
GI ALLIANCE - GURNEE ( Site 0107), Gurnee, Illinois
Iowa Digestive Disease Center ( Site 0123), Clive, Iowa
University of Louisville Hospital-Clinical Trials Unit ( Site 0165), Louisville, Kentucky
Baton Rouge General Medical Center - Bluebonnet ( Site 0112), Baton Rouge, Louisiana
Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 0154), New Orleans, Louisiana
Walter Reed National Military Medical Center ( Site 0121), Bethesda, Maryland
Woodholme Gastroenterology Associates-Woodholme Gastroenterology Associates ( Site 3835), Glen Burnie, Maryland
Massachusetts General Hospital-Crohn's and Colitis Center ( Site 0132), Boston, Massachusetts
University of Michigan ( Site 0143), Ann Arbor, Michigan
Clinical Research Institute of Michigan, LLC ( Site 0108), Clinton Township, Michigan
Michigan Center of Medical Research (MICHMER) ( Site 3850), Farmington Hills, Michigan
Clinical Research Institute of Michigan, LLC ( Site 0150), Troy, Michigan
Huron Gastroenterology ( Site 3836), Ypsilanti, Michigan
Mayo Clinic in Rochester, Minnesota ( Site 0147), Rochester, Minnesota
BVL Research - Kansas ( Site 3847), Liberty, Missouri
Washington University School of Medicine ( Site 0129), Saint Louis, Missouri
Circuit Clinical /Middletown Medical PC ( Site 3831), Middletown, New York
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 3846), New York, New York
Lenox Hill Hospital ( Site 0128), New York, New York
New York Gastroenterology Associates ( Site 0159), New York, New York
University of North Carolina Medical Center ( Site 0140), Chapel Hill, North Carolina
Carolina Digestive Diseases and Endoscopy Center ( Site 3809), Greenville, North Carolina
Hospital of the University of Pennsylvania ( Site 0170), Philadelphia, Pennsylvania
University Gastroenterology ( Site 0164), Providence, Rhode Island
Gastroenterology Associates of Orangeburg ( Site 0149), Orangeburg, South Carolina
Vanderbilt Inflammatory Bowel Disease Clinic ( Site 0131), Nashville, Tennessee
Quality Medical Research ( Site 3807), Nashville, Tennessee
GI Alliance - Garland ( Site 0109), Garland, Texas
Baylor College of Medicine Medical Center ( Site 3812), Houston, Texas
The University of Texas Health Science Center at Houston-Internal Medicine-Division of Gastroentero ( Site 0144), Houston, Texas
Clinical Trial Network ( Site 3819), Houston, Texas
GI Alliance - Lubbock ( Site 0167), Lubbock, Texas
Caprock Gastro Research ( Site 0101), Lubbock, Texas
GI Alliance: Mansfield ( Site 0161), Mansfield, Texas
CARTA - Clinical Associates In Research Therapeutics Of America ( Site 0122), San Antonio, Texas
Southern Star Research Institute ( Site 0106), San Antonio, Texas
GI Alliance - San Marcos ( Site 0130), San Marcos, Texas
GI Alliance - Southlake ( Site 0104), Southlake, Texas
Tyler Research Institute ( Site 0105), Tyler, Texas
Texas Digestive Disease Consultants ( Site 0136), Webster, Texas
Velocity Clinical Research, Salt Lake City ( Site 3801), West Jordan, Utah
Richmond VA Medical Center ( Site 3845), Richmond, Virginia
Washington Gastroenterology - Bellevue ( Site 3844), Bellevue, Washington
Washington Gastroenterology - Tacoma ( Site 0102), Tacoma, Washington
MEDICAL COLLEGE OF WISCONSIN ( Site 0141), Milwaukee, Wisconsin
Centro de Investigaciones Médicas Mar del Plata ( Site 2101), Mar del Plata, Buenos Aires
CER medical Institute-Gastroenterology ( Site 2110), Quilmes, Caba
Hospital Provincial del Centenario ( Site 2108), Rosario, Santa Fe
C.I.C.E. 9 de Julio-CICE 9 DE JULIO ( Site 2103), San Miguel de Tucumán, Tucuman
Nepean Hospital-Gastroenterology/Hepatology ( Site 2501), Kingswood, New South Wales
Concord Repatriation General Hospital-Gastroenterology and Liver Services ( Site 2508), Sydney, New South Wales
Royal Brisbane and Women's Hospital ( Site 2500), Brisbane, Queensland
Mater Misericordiae Limited-Gastroenterology ( Site 2506), Brisbane, Queensland
Royal Adelaide Hospital-Gastroenterology/Hepatology ( Site 2504), Adelaide, South Australia
Monash Health-Gastroenterology ( Site 2505), Clayton, Victoria
The Alfred Hospital-Gastroenterology ( Site 2503), Melbourne, Victoria
St Vincent's Hospital ( Site 2510), Melbourne, Victoria
Universitaetsklinik fuer Innere Medizin I Innsbruck ( Site 0200), Innsbruck, Tirol
Medizinische Universität Wien-Klinik für Innere Medizin III - Abteilung für Gastroenterologie und H ( Site 0202), Vienna, Wien
Uniklinikum Salzburg-Innere Medizin I ( Site 0201), Salzburg, Not set
UZ Gent ( Site 0300), Gent, Oost-Vlaanderen
UZ Leuven-Gastroenterology - Inflammatory Bowel Disease ( Site 0301), Leuven, Vlaams-Brabant
MC Velingrad 2017 EOOD ( Site 0406), Velingrad, Pazardzhik
"Diagnostic - Consultative Center XX - Sofia" EOOD ( Site 0407), Sofia, Sofia (stolitsa)
DKC V - Plovdiv ( Site 0402), Plovdiv, Not set
MC Rusemed ( Site 0408), Ruse, Not set
MHAT Hadzhi Dimitar-Gastroenterology ( Site 0403), Sliven, Not set
Diagnostic Consultative Center 22 - Sofia ( Site 0401), Sofia, Not set
4th MHAT ( Site 0409), Sofia, Not set
Medica Plus Medical Center ( Site 0404), Veliko Tarnovo, Not set
Heritage Medical Research Clinic ( Site 0004), Calgary, Alberta
Gastroenterology and internal medicine research institute ( Site 0010), Edmonton, Alberta
SIX08 Gastroenterology ( Site 0013), Lethbridge, Alberta
Fraser Clinical Trials Inc. ( Site 0019), New Westminster, British Columbia
G.I.R.I. GI Research Institute Foundation ( Site 0001), Vancouver, British Columbia
Private Practice - Dr. Bruce Musgrave ( Site 0011), Kentville, Nova Scotia
Barrie GI Associates ( Site 0012), Barrie, Ontario
University Hospital - London Health Sciences Centre ( Site 0002), London, Ontario
Victoria Hospital & Children's Hospital - London Health Sciences Centre ( Site 0007), London, Ontario
West GTA Research Inc. ( Site 0017), Mississauga, Ontario
Toronto Immune & Digestive Health Institute ( Site 0005), Toronto, Ontario
Toronto Digestive Disease Associates ( Site 0006), Vaughan, Ontario
Centre Intégré de Santé et Service Sociaux de Chaudière-Appalaches ( Site 0015), Levis, Quebec
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0018), Montreal, Quebec
Montreal General Hospital ( Site 0003), Montreal, Quebec
ABP Research Services Corp. ( Site 0016), Ontario, Not set
Diex Recherche Quebec ( Site 0008), Quebec, Not set
Clinical Research Chile SpA ( Site 2201), Valdivia, Los Rios
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 2203), Santiago., Region M. De Santiago
FALP-UIDO ( Site 2208), Santiago, Region M. De Santiago
Clínica Universidad de Los Andes ( Site 2202), Santiago, Region M. De Santiago
Clínica Alemana de Santiago ( Site 2209), Santiago, Region M. De Santiago
Clínica MEDS La Dehesa ( Site 2207), Santiago, Region M. De Santiago
CECIM ( Site 2200), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile-CICUC ( Site 2205), Santiago, Region M. De Santiago
The First Affiliated Hospital of Anhui Medical University ( Site 3957), Hefei, Anhui
Anhui Provincial Hospital ( Site 3947), Hefei, Anhui
Beijing Friendship Hospital Affiliate of Capital University ( Site 3923), Beijing, Beijing
Peking University Third Hospital ( Site 3909), Beijing, Beijing
Beijing Luhe Hospital Capital Medical University ( Site 3911), Beijing, Beijing
Chongqing University Three Gorges Hospital ( Site 3928), Chongqing, Chongqing
The First Affiliated Hospital Of Fujian Medical University ( Site 3904), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University-Gastroenterology ( Site 3954), Xiamen, Fujian
Dongguan People's Hospital-Gastroenterology department ( Site 3944), Dongguan, Guangdong
Guangzhou Medical University 2nd Hospital ( Site 3908), Guangzhou, Guangdong
Southern Medical University Nanfang Hospital-Gastroenterology ( Site 3914), Guangzhou, Guangdong
The Sixth Affiliated Hospital of Sun Yat-sen University ( Site 3906), Guangzhou, Guangdong
Huizhou Municipal Central Hospital ( Site 3917), Huizhou, Guangdong
Yuebei People's Hospital Guangdong ( Site 3948), Shaoguan, Guangdong
The University of Hong Kong-Shenzhen Hospital ( Site 3955), Shenzhen, Guangdong
Shenzhen Hospital of Southern Medical University-Gastroenterology department ( Site 3905), Shenzhen, Guangdong
The Second Hospital of Hebei Medical University ( Site 3934), Shijiazhuang, Hebei
The Second Affiliated Hospital of Zhengzhou University ( Site 3935), Zhengzhou, Henan
Taihe Hospital ( Site 3941), Shiyan, Hubei
The Central Hospital of Wuhan ( Site 3939), Wuhan, Hubei
Renmin Hospital of Wuhan University ( Site 3912), Wuhan, Hubei
The Second Xiangya Hospital of Central South University ( Site 3930), Changsha, Hunan
Changzhou No.2 People's Hospital ( Site 3950), Changzhou, Jiangsu
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 3900), NanJing, Jiangsu
Zhongda Hospital Southeast University ( Site 3919), Nanjing, Jiangsu
Wuxi People's Hospital ( Site 3920), Wuxi, Jiangsu
The First Affiliated Hospital of Nanchang University ( Site 3926), Nanchang, Jiangxi
Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army ( Site 3929), Xian, Shaanxi
Binzhou Medical University Hospital ( Site 3953), Binzhou, Shandong
Taian City Central Hospital-gastroenterology department ( Site 3946), Taian, Shandong
Ruijin Hospital Shanghai Jiaotong University School of Medicine-Gastroneterology ( Site 3903), Shanghai, Shanghai
Shanghai East Hospital ( Site 3922), Shanghai, Shanghai
Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 3915), Shanghai, Shanghai
West China Hospital, Sichuan University ( Site 3951), Cheng Du, Sichuan
Tianjin Medical University General Hospital ( Site 3945), Tianjin, Tianjin
The First Teaching Hospital of Xinjiang Medical University. ( Site 3937), Urumqi, Xinjiang
First Affiliated Hospital of Kunming Medical University ( Site 3925), Kunming, Yunnan
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine-GI Medicine ( Site 3916), Hangzhou, Zhejiang
Clínica las Américas ( Site 2318), Medellín, Antioquia
Clinica Medellin S.A ( Site 2317), Medellín, Antioquia
Clinica Somer-Unidad de Investigacion y Docencia ( Site 2303), Rionegro, Antioquia
Clinica de la Costa S.A.S. ( Site 2305), Barranquilla, Atlantico
Fundacion Santa Fe de Bogota ( Site 2316), Bogota, Cundinamarca
Oncologos del Occidente ( Site 2310), Pereira., Risaralda
Fundación Valle del Lili ( Site 2307), Cali, Valle Del Cauca
Klinička bolnica Merkur ( Site 0505), Zagreb, Grad Zagreb
Klinički bolnički centar Zagreb ( Site 0501), Zagreb, Grad Zagreb
Poliklinika Bates ( Site 0504), Zagreb, Grad Zagreb
Poliklinika Solmed ( Site 0502), Zagreb, Grad Zagreb
Poliklinika Borzan ( Site 0500), Osijek, Osjecko-baranjska Zupanija
Klinički Bolnički Centar Split ( Site 0503), Split, Splitsko-dalmatinska Zupanija
Vojenská Nemocnice Brno-Internal department ( Site 0605), Brno, Brno-mesto
Institut Klinicke a Experimentalni Mediciny-Klinika hepatogastroentrologie ( Site 0604), Praha, Praha 4
Nemocnice Slany ( Site 0601), Slany, Stredocesky Kraj
Hepato-Gastroenterologie HK ( Site 0602), Hradec Kralove, Not set
CEMDOE - Centro Médico de Diabetes, Obesidad y Especialidades ( Site 3601), Santo Domingo, Distrito Nacional
Tampereen yliopistollinen sairaala ( Site 4300), Tampere, Pirkanmaa
Pohjois-Karjalan keskussairaala ( Site 4302), Joensuu, Pohjois-Karjala
Turku University Hospital ( Site 4301), Turku, Varsinais-Suomi
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 0706), Nice, Alpes-Maritimes
CHU Bordeaux Haut-Leveque-Service d'Hépato-gastroentérologie ( Site 0700), Pessac, Aquitaine
Assistance Publique Hôpitaux de Marseille - Hôpital Nord ( Site 0714), Marseille, Bouches-du-Rhone
Centre Hospitalier Universitaire de Reims - Hôpital Robert Debré ( Site 0705), Reims, Champagne-Ardenne
CHU Besançon ( Site 0710), Besançon, Doubs
C.H.U. de Nimes. Hopital Caremeau ( Site 0718), Nimes, Gard
Hopital Beaujon ( Site 0716), Clichy, Hauts-de-Seine
CMC Ambroise Paré Hartmann - Institut des MICI ( Site 0709), Neuilly-sur-Seine, Hauts-de-Seine
CHU SAINT ELOI ( Site 0711), Montpellier, Languedoc-Roussillon
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu ( Site 0701), Nantes, Loire-Atlantique
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois ( Site 0708), Vandoeuvre lès Nancy, Meurthe-et-Moselle
centre hospitalier lyon sud ( Site 0707), Pierre-Bénite, Rhone
CHU d'Amiens-Picardie - Hôpital Sud-Hepato-gastroentérology ( Site 0712), Amiens, Somme
Hopital Henri Mondor ( Site 0717), Creteil, Val-de-Marne
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre ( Site 0715), Le Kremlin-Bicêtre, Val-de-Marne
Hôpital Saint Antoine ( Site 0703), Paris, Not set
Hôpital Saint-Louis ( Site 0702), Paris, Not set
LTD High Technology Hospital Medcenter ( Site 0802), Batumi, Ajaria
Caucasus Medical Centre ( Site 0801), Tbilisi, Ajaria
Caraps Medline ( Site 0803), Tbilisi, Not set
New Hospitals ( Site 0800), Tbilisi, Not set
Universitaetsklinikum Ulm. ( Site 0902), Ulm, Baden-Wurttemberg
Klinikum der Universität München Großhadern-Medizinische Klinik und Poliklinik II ( Site 0907), Munich, Bayern
Agaplesion Markus Krankenhaus ( Site 0904), Frankfurt am Main, Hessen
Medizinische Hochschule Hannover ( Site 0913), Hannover, Niedersachsen
Klinikum Lüneburg ( Site 0908), Lüneburg, Niedersachsen
Stadtische Kliniken Duisburg, Abtlg. Innere Medizin ( Site 0916), Duisburg, Nordrhein-Westfalen
Gastroenterologische Gemeinschaftspraxis Minden ( Site 0911), Minden, Nordrhein-Westfalen
Medizinisches Versorgungszentrum Portal 10 ( Site 0914), Münster, Nordrhein-Westfalen
St. Marien und St. Annastift Krankenhaus ( Site 0901), Ludwighafen Am Rhein, Rheinland-Pfalz
Universitätsklinikum Leipzig ( Site 0909), Leipzig, Sachsen
Universitaetsklinikum Schleswig-Holstein Campus Kiel ( Site 0903), Kiel, Schleswig-Holstein
Charité Campus Virchow-Klinikum ( Site 0906), Berlin, Not set
Städtisches Klinikum Brandenburg ( Site 0905), Brandenburg, Not set
Evangelismos General Hospital of Athens ( Site 4001), Athens, Attiki
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 4000), Athens, Attiki
General Hospital of Nikaia-Piraeus "Agios Panteleimon" ( Site 4006), Nikaia Piraeus, Attiki
Ippokrateio General Hospital of Thessaloniki ( Site 4004), Thessaloniki, Kentriki Makedonia
University General Hospital of Heraklion-GASTROENTEROLOGY & HEPATOLOGY ( Site 4003), Heraklion, Kriti
Csőszi Endoszkópos KFT ( Site 1001), Kecskemét, Bacs-Kiskun
Mohácsi Kórház ( Site 1008), Mohács, Baranya
Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórház-4. Belgyogyaszat Gasztroenterologia ( Site 1007), Békéscsaba, Bekescsaba
Heves Vármegyei Markhot Ferenc Oktatókórház és Rendelőintézet ( Site 1012), Eger, Heves
Gyöngyösi Bugát Pál Kórház ( Site 1011), Gyongyos, Heves
Komarom-Esztergom Varmegyei Szent Borbala Korhaz ( Site 1010), Tatabánya, Komarom-Esztergom
VeszLife Magánklinika ( Site 1002), Veszprém, Veszprem
Synexus Magyarorszag Kft. (Budapest DRS) ( Site 1009), Budapest, Not set
Semmelweis Egyetem ( Site 1006), Budapest, Not set
Pannónia Magánorvosi Centrum ( Site 1004), Budapest, Not set
Emek Medical Center ( Site 1106), Afula, Not set
Barzilai Medical Center ( Site 1109), Ashkelon, Not set
Rambam Health Care Campus ( Site 1101), Haifa, Not set
Bnai Zion Medical Center ( Site 1103), Haifa, Not set
Edith Wolfson Medical Center ( Site 1104), Holon, Not set
Shaare Zedek Medical Center ( Site 1108), Jerusalem, Not set
Meir Medical Center. ( Site 1102), Kfar Saba, Not set
Rabin Medical Center ( Site 1107), Petah Tikva, Not set
Sheba Medical Center ( Site 1100), Ramat Gan, Not set
Policlinico Universitario Monserrato-SC Gastroenterologia ( Site 1207), Monserrato, Cagliari
IRCCS Casa Sollievo della Sofferenza ( Site 1213), San Giovanni Rotondo, Foggia
Fondazione Policlinico Tor Vergata ( Site 1209), Rome, Lazio
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico-Gastroenterology and Endoscopy Unit ( Site 1202), Milano, Lombardia
Istituto Clinico Humanitas-IBD center ( Site 1201), Rozzano, Lombardia
Ospedale Di Circolo-U.O.C. di Gastroenterologia ed Endoscopia Digestiva ( Site 1216), Rho, Milano
A.O.R.N. Ospedale dei Colli - Monaldi V. ( Site 1217), Napoles, Napoli
Azienda Ospedaliera San Camillo Forlanini ( Site 1204), Rome, Roma
Fatebenefratelli Isola Tiberina - Gemelli Isola ( Site 1214), Rome, Roma
Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO-U.O.S.D. Malattie Infiammatorie Croniche Intestinali ( Site 1210), Palermo, Sicilia
Azienda Ospedale - Università Padova-Surgery Oncology and Gastroenterology ( Site 1211), Padova, Veneto
Ospedale Sacro Cuore Don G. Calabria ( Site 1212), Negrar, Verona
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1208), Bologna, Not set
ASST Fatebenefratelli Sacco-UOC Gastroenterologia ( Site 1200), Milano, Not set
Ospedale San Raffaele-Gastroenterology and Gastrointestinal Endoscopy ( Site 1205), Milano, Not set
Fondazione IRCCS Policlinico San Matteo-General Medicine ( Site 1206), Pavia, Not set
Aichi Medical University Hospital ( Site 2841), Nagakute, Aichi
Tokatsu Tsujinaka Hospital ( Site 2832), Abiko, Chiba
Tsujinaka Hospital - Kashiwanoha ( Site 2802), Kashiwa, Chiba
Toho University Sakura Medical Center ( Site 2805), Sakura, Chiba
Ehime Prefectural Central Hospital ( Site 2868), Matsuyama, Ehime
Kitakyushu Municipal Medical Center ( Site 2873), Kitakyushu, Fukuoka
Kurume University Hospital ( Site 2846), Kurume, Fukuoka
Gunma University Hospital ( Site 2850), Maebashi, Gunma
National Hospital Organization Fukuyama Medical Center ( Site 2831), Fukuyama, Hiroshima
Asahikawa City Hospital ( Site 2840), Asahikawa, Hokkaido
Asahikawa Medical University Hospital ( Site 2815), Asahikawa, Hokkaido
Sapporo Tokushukai Hospital ( Site 2808), Sapporo, Hokkaido
Sapporo Medical University Hospital ( Site 2829), Sapporo, Hokkaido
Medical Corporation Sapporo IBD Clinic ( Site 2842), Sapporo, Hokkaido
Sapporohigashi Tokushukai Hospital ( Site 2860), Sapporo, Hokkaido
Hyogo Medical University Hospital ( Site 2830), Nishinomiya, Hyogo
Hitachi General Hospital ( Site 2856), Hitachi, Ibaraki
Ishikawa Prefectural Central Hospital ( Site 2835), Kanazawa, Ishikawa
Kanazawa University Hospital ( Site 2839), Kanazawa, Ishikawa
Iwate Medical University Uchimaru Medical Center ( Site 2833), Morioka, Iwate
Gokeikai Ofuna Chuo Hospital ( Site 2801), Kamakura, Kanagawa
St. Marianna University Hospital ( Site 2852), Kawasaki, Kanagawa
Matsushima Hospital ( Site 2822), Yokohama, Kanagawa
Yokohama City University Medical Center ( Site 2865), Yokohama, Kanagawa
Mie University Hospital ( Site 2838), Tsu, Mie
Sai Gastroenterology/Proctology Clinic ( Site 2814), Fujiidera, Osaka
Kansai Medical University Hospital ( Site 2823), Hirakata, Osaka
Hamamatsu University Hospital ( Site 2874), Hamamatsu, Shizuoka
Matsuda Hospital ( Site 2826), Hamamatsu, Shizuoka
National Hospital Organization Shizuoka Medical Center ( Site 2837), Shimizu, Shizuoka
Institute of Science Tokyo Hospital ( Site 2827), Bunkyō, Tokyo
Ginza Central Clinic ( Site 2824), Chuo, Tokyo
Toranomon Hospital ( Site 2828), Minato-ku, Tokyo
Kitasato University Kitasato Institute Hospital ( Site 2817), Minato-ku, Tokyo
The Jikei University Hospital ( Site 2843), Minato, Tokyo
Kyorin University Hospital ( Site 2804), Mitaka-shi, Tokyo
NTT Medical Center Tokyo ( Site 2834), Shinagawa-ku, Tokyo
Yamanashi Prefectural Central Hospital ( Site 2836), Kofu, Yamanashi
Fukui Prefectural Hospital ( Site 2844), Fukui, Not set
Fukuoka University Hospital ( Site 2818), Fukuoka, Not set
Hiroshima University Hospital ( Site 2845), Hiroshima, Not set
Kagoshima University Hospital ( Site 2848), Kagoshima, Not set
Kagoshima IBD Gastroenterology Clinic ( Site 2821), Kagoshima, Not set
University Hospital,Kyoto Prefectural University of Medicine ( Site 2819), Kyoto, Not set
National Hospital Organization Kyoto Medical Center ( Site 2813), Kyoto, Not set
Ishida Clinic of IBD and Gastroenterology ( Site 2820), Oita, Not set
Okayama University Hospital ( Site 2870), Okayama, Not set
Infusion Clinic ( Site 2806), Osaka, Not set
National Hospital Organization Osaka National Hospital ( Site 2869), Osaka, Not set
Saga University Hospital ( Site 2812), Saga, Not set
Tokitokai Tokito Clinic Coloproctology Center ( Site 2811), Saitama, Not set
Tokyo Yamate Medical Center ( Site 2803), Tokyo, Not set
Toyama Prefectural Central Hospital ( Site 2807), Toyama, Not set
Yamagata University Hospital ( Site 2849), Yamagata, Not set
Wonju Severance Christian Hospital-Internal Medicine ( Site 3003), Wonju, Kang-won-do
The Catholic University Of Korea St. Vincent's Hospital-Gastroenterology ( Site 3006), Suwon-si, Kyonggi-do
Dong-A University Hospital ( Site 3010), Busan, Pusan-Kwangyokshi
Inje University Haeundae Paik Hospital ( Site 3009), Haeundae-gu, Pusan-Kwangyokshi
Chung-Ang University Hospital ( Site 3008), Dongjak-gu, Seoul
Yeungnam University Medical Center ( Site 3004), Daegu, Taegu-Kwangyokshi
The Catholic University of Korea, Daejeon St. Mary's Hospital ( Site 3011), Daejeon, Taejon-Kwangyokshi
Kyung Hee University Hospital ( Site 3013), Seoul, Not set
Seoul National University Hospital ( Site 3005), Seoul, Not set
Kangbuk Samsung Hospital-Internal Medicine ( Site 3002), Seoul, Not set
The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3012), Seoul, Not set
Severance Hospital, Yonsei University Health System-Department of Internal Medicine ( Site 3000), Seoul, Not set
Asan Medical Center ( Site 3007), Seoul, Not set
Samsung Medical Center ( Site 3001), Seoul, Not set
SIA M & M Centrs ( Site 4502), Adazi, Adazu Novads
Liepaja Regional Hospital ( Site 4501), Liepaja, Not set
Hospital of Lithuanian University of Health Sciences Kauno klinikos ( Site 4600), Kaunas, Kauno Apskritis
VUL SANTAROS KLINIKOS ( Site 4601), Vilnius, Vilniaus Miestas
Hospital Tuanku Jaafar Seremban ( Site 4705), Seremban, Negeri Sembilan
Hospital Ampang ( Site 4703), Ampang, Selangor
Medica Sur-Clinica de Enfermedades Digestivas y Obesidad ( Site 2406), Mexico City, Distrito Federal
Morales Vargas Centro de Investigacion ( Site 2411), León, Guanajuato
PanAmerican Clinical Research - Guadalajara ( Site 2400), Guadalajara, Jalisco
Centro Medico Clinico Quirurgico Especializado en Investigación ( Site 2403), Tlajumulco De Zuniga, Jalisco
Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 2409), Monterrey, Nuevo Leon
Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan ( Site 2407), Merida, Yucatan
ICARO Investigaciones en Medicina ( Site 2405), Chihuahua, Not set
Centro de Investigación y Gastroenterología - S.C. ( Site 2410), Mexico City, Not set
Oaxaca Site Management Organization S.C. ( Site 2404), Oaxaca, Not set
Radboudumc ( Site 1402), Nijmegen, Gelderland
ETZ Elisabeth-Department of Gastroenterology and Hepatology ( Site 1403), Tilburg, Noord-Brabant
Ziekenhuis Bernhoven-Researchbureau ( Site 1401), Uden, Noord-Brabant
Onze Lieve Vrouwe Gasthuis ( Site 1405), Amsterdam, Noord-Holland
Amsterdam UMC, locatie VUmc-IBD Trial Unit ( Site 1400), Amsterdam, Noord-Holland
Deventer Ziekenhuis ( Site 1411), Deventer, Overijssel
Erasmus Medisch Centrum ( Site 1410), Rotterdam, Zuid-Holland
Franciscus Gasthuis & Vlietland, Locatie Gasthuis ( Site 1406), Rotterdam, Zuid-Holland
Universitair Medisch Centrum Utrecht ( Site 1404), Utrecht, Not set
Waikato Hospital ( Site 2903), Hamilton, Waikato
Hutt Valley District Health board HVDHB ( Site 2902), Lower Hutt, Wellington
Aotearoa Clinical Trials ( Site 2900), Auckland, Not set
Akershus Universitetssykehus ( Site 4200), Lørenskog, Akershus
Oslo Universitetssykehus Ullevål ( Site 4201), Oslo, Not set
Planetmed ( Site 1506), Wroclaw, Dolnoslaskie
Melita Medical ( Site 1519), Wroclaw, Dolnoslaskie
EMC Instytut Medyczny SA ( Site 1505), Wroclaw, Dolnoslaskie
Gastromed Sp. z o. o. ( Site 1513), Torun, Kujawsko-pomorskie
Med-Gastr Sp. z o.o., sp.k ( Site 1515), Lodz, Lodzkie
AmiCare Centrum Medyczne - Zgierska ( Site 1517), Lodz, Lodzkie
Allmedica ( Site 1508), Nowy Targ, Malopolskie
Vivamed Sp. z o.o. ( Site 1510), Warsawa, Mazowieckie
Centrum Zdrowia MDM ( Site 1512), Warszawa, Mazowieckie
WIP Warsaw IBD Point Profesor Kierkuś ( Site 1503), Warszawa, Mazowieckie
Twoja Przychodnia - Szczecinskie Centrum Medyczne ( Site 1502), Szczecin, Zachodniopomorskie
Sonomed Sp. z o. o. ( Site 1516), Szczecin, Zachodniopomorskie
Unidade Local de Saude Lisboa Ocidental - Hospital Egas Moniz ( Site 3306), Lisbon, Lisboa
Unidade Local de Saude de Braga - Hospital de Braga ( Site 3300), Braga, Not set
Hospital dos Lusíadas Lisboa ( Site 3303), Lisboa, Not set
Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 3305), Lisboa, Not set
ULSAM - Hospital de Santa Luzia ( Site 3302), Viana do Castelo, Not set
Unidade Local de Saude Dão-Lafões - Hospital de São Teotónio ( Site 3308), Viseu, Not set
MEMORIAL HEALTHCARE INTERNATIONAL S.R.L ( Site 1606), Bucharest, Bucuresti
Fundeni Clinical Institute-Gastroenterology and Hepatology Center ( Site 1608), București, Bucuresti
Spitalul Clinic Judetean de Urgenta Cluj Napoca-Gastroenterology ( Site 1605), Cluj Napoca, Cluj
GastroMed ( Site 1609), Cluj-Napoca, Cluj
Spitalul Clinic Judetean Mures-Gastroenterology ( Site 1607), Targu Mures, Mures
S.C Centrul de Gastroenterologie Dr. Goldis S.R.L-Gastroenterology ( Site 1601), Timisoara, Timis
Asociatia Oncohelp ( Site 1610), Timisoara, Timis
S.C. Centrul Medical Medicum SRL-Gastroenterology ( Site 1604), Bucuresti, Not set
Clinical Hospital Center Dragisa Misovic ( Site 1708), Belgrade, Beograd
Clinical Hospital Center Zvezdara-Gastroenterology and hepatology Department ( Site 1705), Belgrade, Beograd
University Medical Center "Bezanijska kosa"-Gastroenterology and hepatology ( Site 1704), Belgrade, Beograd
Clinical Center Kragujevac ( Site 1703), Kragujevac, Beograd
General Hospital "Djordje Joanovic" ( Site 1707), Zrenjanin, Srednjebanatski Okrug
Breznianske centrum gastroenterologie ( Site 1806), Brezno, Banskobystricky Kraj
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica ( Site 1802), Slovakia, Banskobystricky Kraj
Cliniq s.r.o. ( Site 1800), Bratislava, Bratislavsky Kraj
ENDOMED ( Site 1801), Kosice, Kosicky Kraj
KM Management ( Site 1804), Nitra, Nitriansky Kraj
Accout Center ( Site 1805), Sahy, Nitriansky Kraj
GASTRO I ( Site 1807), Presov, Presovsky Kraj
Gastro LM ( Site 1808), Presov, Presovsky Kraj
Wits Clinical Research-Research ( Site 3208), Johannesburg, Gauteng
Wits Clinical Research-Wits Clinical Research Bara ( Site 3206), Soweto, Gauteng
Panorama Medical Centre ( Site 3209), Cape Town, Western Cape
Spoke Research ( Site 3210), Cape Town, Western Cape
Life Kingsbury Hospital ( Site 3203), Cape Town, Western Cape
Private Practice - Dr. M.N. Rajabally ( Site 3213), Cape Town, Western Cape
Hospital Germans Trias i Pujol ( Site 3413), Badalona, Barcelona
Hospital Universitari Mutua Terrassa ( Site 3416), Terrassa, Barcelona
Hospital Galdakao-Usansolo ( Site 3409), Galdakao-Usansolo, Bizkaia
Hospital La Princesa-Gastroenterology ( Site 3411), Madrid, Madrid, Comunidad De
Fundación Jimenez Diaz ( Site 3420), Madrid, Madrid, Comunidad De
Hospital Universitario de Torrejon ( Site 3417), Torrejón de Ardoz, Madrid, Comunidad De
Hospital Universitario de Fuenlabrada-Digestive ( Site 3415), Fuenlabrada, Madrid
HOSPITAL CLINICO DE VALENCIA ( Site 3406), Valencia, Valenciana, Comunitat
Hospital Universitari i Politecnic La Fe-Enfermedad Inflamatoria Intestinal ( Site 3405), València, Valencia
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-Aparato Digestivo ( Site 3403), Madrid, Not set
Hospital Universitario La Paz-Unidad de Enfermedad Inflamatoria Intestinal ( Site 3402), Madrid, Not set
Universitetssjukhuset i Linköping ( Site 4402), Linköping, Ostergotlands Lan
Danderyds Sjukhus ( Site 4401), Danderyd, Stockholms Lan
Karolinska Universitetssjukhuset Solna ( Site 4400), Stockholm, Stockholms Lan
Akademiska Sjukhuset ( Site 4403), Uppsala, Uppsala Lan
INTESTO-Gastroenterologische Praxis / Crohn-Colitis Zentrum Bern ( Site 1902), Bern, Berne
Cantonal Hospital St.Gallen-Klinik für Gastroenterologie / Hepatologie ( Site 1901), St.Gallen, Sankt Gallen
UniversitätsSpital Zürich-Gastroenterologie & Hepatologie ( Site 1900), Zürich, Zurich
Changhua Christian Hospital ( Site 3104), Changhua County, Changhua
National Taiwan University BioMedical Park Hospital ( Site 3103), Zhu Bei City, Hsinchu
China Medical University Hospital ( Site 3100), Taichung, Not set
National Taiwan University Hospital ( Site 3102), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch ( Site 3101), Taoyuan, Not set
Istanbul Universitesi Cerrahpasa-Internal Diseases ( Site 3503), Istanbul- Fatih, Istanbul
ANKARA UNIVERSITY IBNI SINA HOSPITAL ( Site 3507), Ankara, Not set
Hacettepe Universite Hastaneleri ( Site 3500), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Gastroenterology ( Site 3501), Ankara, Not set
Antalya Egitim ve Arastirma Hastanesi ( Site 3508), Antalya, Not set
Trakya University Medical Faculty Hospital ( Site 3510), Edirne, Not set
Eskisehir Osmangazi University Faculty of Medicine ( Site 3512), Eskisehir, Not set
Marmara Universitesi Pendik Egitim Arastirma Hastanesi ( Site 3505), Istanbul, Not set
Kocaeli University Medical Faculty Hospital ( Site 3509), Kocaeli, Not set
Communal non-profit enterprise "Regional clinical hospital of Ivano-Frankivsk Regional Council" ( Site 4115), Ivano-Frankivsk, Ivano-Frankivska Oblast
Center of Family Medicine Plus-Treatment Prevention Unit ( Site 4103), Kyiv, Kyivska Oblast
Communal Non-profit Enterprise of Lviv Regional Council "Lviv Regional Clinical Hospital"-proctology ( Site 4109), Lviv, Lvivska Oblast
Limited liability company "Medical center Health Clinic"-Gastroenterology, Hepatology and Endocrino ( Site 4107), Vinnytsia, Vinnytska Oblast
Communal Non-Commercial Enterprise "Vinnytsia City Clinical -Clinical Therapeutic Department #1 ( Site 4111), Vinnytsia, Vinnytska Oblast
Municipal Nonprofit Enterprise "Vinnytsia Regional Clinical -Gastroenterology department ( Site 4114), Vinnytsya, Vinnytska Oblast
Municipal Enterprise "Volyn Regional Clinical Hospital" of V-surgery department (abdominal, colopro ( Site 4113), Lutsk, Volynska Oblast
Medical Center "Universal Clinic "Oberig" of Limited Liability Company "Kapytal" ( Site 4100), Kyiv, Not set
Dobrobut Medical Center ( Site 4101), Kyiv, Not set
Medical Center of Private Enterprise "Sygma" ( Site 4108), Kyiv, Not set
Southmead Hospital ( Site 2004), Bristol, Bristol, City Of
Addenbrooke's Hospital ( Site 2005), Cambridge, Cambridgeshire
Royal Devon & Exeter Hospital-IBD Research Group ( Site 2001), Exeter, Devon
Doncaster Royal Infirmary ( Site 2006), Doncaster, England
Huddersfield Royal Infirmary ( Site 2010), Huddersfield, England
Whipps Cross University Hospital-Clinical Research Unit ( Site 2000), London, England
St. George's Hospital ( Site 2007), London, England
Southampton General Hospital-Gastroenterology ( Site 2003), Southampton, Hampshire
University College London Hospital-Clinical Research Facility ( Site 2002), London, London, City Of
Walsall Manor Hospital ( Site 2009), West Midlands, Walsall
Conditions: Ulcerative Colitis
Outcomes From Remediation and Behavioural Intervention Techniques
Recruiting
It is currently unknown what factors predict response to Cognitive Behavioural Therapy for Psychosis (CBTp) or Cognitive Remediation Therapy (CR) among individuals with schizophrenia-spectrum disorders, thus the current trial will examine predictors of response to determine who requires the combined intervention and who might respond sufficiently to either monotherapy.
It is currently unknown what factors predict response to Cognitive Behavioural Therapy for Psychosis (CBTp) or Cognitive Remediation Therapy (CR) among individuals with schizophrenia-spectrum disorders, thus the current trial will examine predictors of response to determine who requires the combined intervention and who might respond sufficiently to either monotherapy. Read Less
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/13/2025
Locations: University of Toronto Scarborough, Scarborough, Ontario +1 locations
University of Toronto Scarborough, Scarborough, Ontario
Ontario Shores Centre for Mental Health Sciences (Ontario Shores), Whitby, Ontario
Conditions: Schizophrenia, Psychosis, Psychotic Disorders, Schizophrenia; Psychosis
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Recruiting
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer).
This study is seeking participants who:
* Are 18 years of age or older and have MM.
* Have received treatments before for MM.
* Have MM that has returned or not responded to their most recent treatment.
Half of the participants will receive elranatamab. The other half of participants will receive a combination t... Read More
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer).
This study is seeking participants who:
* Are 18 years of age or older and have MM.
* Have received treatments before for MM.
* Have MM that has returned or not responded to their most recent treatment.
Half of the participants will receive elranatamab. The other half of participants will receive a combination therapy selected by the study doctor. The selected combination therapy will include 2 to 3 different medicines commonly used to treat MM.
Elranatamab will be given as a shot under the skin at the study clinic about once a week. This may change to a smaller number of shots later in the study.
The medicines in the combination therapy will be taken by mouth (at home or at the study clinic) AND will be given either as:
* a shot under the skin at the study clinic
* through a needle in the vein at the study clinic The number of times these medicines will be taken depends on what combination therapy the study doctor selects.
Participants may continue to receive elranatamab or a combination therapy until their MM is no longer responding. The study team will see how each participant is doing with the study treatment during regular visits at the study clinic. The study team will continue to follow-up with participants after study treatment with telephone contacts (or visits).
The study will compare the experiences of people receiving elranatamab to those people receiving a combination therapy. This will help learn about the safety and how effective elranatamab is. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: Infirmary Cancer Care, Mobile, Alabama +229 locations
Infirmary Cancer Care, Mobile, Alabama
Western Regional Medical Center, Inc. dba. City of Hope Phoenix, Goodyear, Arizona
Beverly Hills Cancer Center, Beverly Hills, California
Community Cancer Institute, Clovis, California
Clinical Research Advisors (Encino Satellite Location), Encino, California
Hoag Health Center Irvine, Irvine, California
Hoag Hospital Irvine, Irvine, California
Clinical Research Advisors (Korea Town Satellite Location), Los Angeles, California
Clinical Research Advisors (West Hollywood Satellite Location), Los Angeles, California
Valkyrie Clinical Trials, Los Angeles, California
Hoag Memorial Hospital Presbyterian, Newport Beach, California
Mission Community Hospital (Satellite Site), Panorama City, California
University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento, California
University of California, Sacramento, California
UCHealth Poudre Valley Hospital, Fort Collins, Colorado
PET Imaging of Northern Colorado, Fort Collins, Colorado
UCHealth Harmony, Fort Collins, Colorado
UCHealth Greeley Hospital, Greeley, Colorado
UCHealth Longs Peak Hospital, Longmont, Colorado
UCHealth Longs Peak Medical Center, Longmont, Colorado
UCHealth - Medical Center of the Rockies, Loveland, Colorado
Baptist Hospital of Miami, Miami, Florida
BRCR Global, Plantation, Florida
BRCR Global - Tamarac, Tamarac, Florida
Midwestern Regional Medical Center, Inc. dba City of Hope Chicago, Zion, Illinois
Community Health Network, Inc., Indianapolis, Indiana
Community Health Network, Inc., Indianapolis, Indiana
Community Health Network, Inc., Indianapolis, Indiana
Beth Israel Deaconess Medical Center, Boston, Massachusetts
BIDMC Research Pharmacy, Boston, Massachusetts
Bryan Medical Center, Lincoln, Nebraska
NHO Revive Research Institute, LLC, Lincoln, Nebraska
Atlantic Health System Morristown Medical Center, Morristown, New Jersey
WMCHealth Advanced Physician Services, Hawthorne, New York
Cayuga Cancer Center at Cayuga Park, Ithaca, New York
Cayuga Medical Center, Ithaca, New York
Westchester Medical Center, Valhalla, New York
Brody school of Medicine at East Carolina University, Greenville, North Carolina
ECU Health Medical Center, Greenville, North Carolina
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
TriHealth Cancer Institute-Good Samaritan Hospital, Cincinnati, Ohio
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
The Jewish Hospital, Cincinnati, Ohio
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
Cleveland Clinic, Cleveland, Ohio
AHN West Penn Hospital, Pittsburgh, Pennsylvania
Brown University Health Cancer Institute, Providence, Rhode Island
The Miriam Hospital, Providence, Rhode Island
St Francis Cancer Center, Greenville, South Carolina
Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy, Dallas, Texas
Baylor University Medical Center, Dallas, Texas
Houston Methodist Hospital, Houston, Texas
Houston Methodist Willowbrook Hospital, Houston, Texas
US Oncology Investigational Products Center (IPC), Irving, Texas
Houston Methodist Sugar Land Hospital, Sugar Land, Texas
Baylor Scott & White Medical Center - Temple, Temple, Texas
WVU Cancer Institute, Morgantown, West Virginia
University of Wisconsin Carbone Cancer Center-University Hospital, Madison, Wisconsin
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin
Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires
Hospital Universitario Austral, Pilar, Buenos Aires
Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Ciudad Autónoma DE Buenos Aires
Hospital Italiano de La Plata, La Plata, Not set
Blacktown Hospital, Blacktown, New South Wales
Concord Repatriation General Hospital, Concord, New South Wales
Sunshine Coast University Hospital, Birtinya, Queensland
Royal Brisbane and Women's Hospital, Brisbane, Queensland
St Vincent's Hospital (Melbourne), Fitzroy, Victoria
Barwon Health, Geelong, Victoria
Clinique Saint Pierre, Ottignies, Brabant Wallon
UZ Brussel, Brussels, Bruxelles-capitale, Région DE
Grand Hôpital de Charleroi, Gilly, Hainaut
Centre Hospitalier Epicura, Hornu, Hainaut
CHR Verviers - La Tourelle, Verviers, Liège
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi, Yvoir, Namur
UZ Gent, Gent, Oost-vlaanderen
AZ Delta vzw, Roeselare, West-vlaanderen
Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador, Salvador, Bahia
Instituto Oncomed de Educação e Pesquisa, Niterói, RIO DE Janeiro
Hospital Moinhos de Vento, Porto Alegre, RIO Grande DO SUL
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, RIO Grande DO SUL
Centro de Pesquisa Clínica - Área Administrativa, Porto Alegre, RIO Grande DO SUL
Hospital Mae de Deus, Porto Alegre, RIO Grande DO SUL
Hospital Amaral Carvalho, Jau, SÃO Paulo
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP), Ribeirão Preto, SÃO Paulo
Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, SÃO Paulo
Clínica Médica São Germano LTDA, SP, SÃO Paulo
Instituto de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, Not set
Americas Centro de Oncologia Integrado, Rio de Janeiro, Not set
Instituto de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, Not set
ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis, São Paulo, Not set
Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set
Hospital do Coracao, São Paulo, Not set
HU UNIFESP / SPDM - Hospital São Paulo, São Paulo, Not set
Universidade Federal de Sao Paulo, São Paulo, Not set
Clínica Médica São Germano S/S Ltda, São Paulo, Not set
Cross Cancer Institute, Edmonton, Alberta
The Moncton Hospital, Moncton, New Brunswick
Jewish General Hospital, Montreal, Quebec
Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎ, Montreal, Quebec
Klinicki bolnicki centar Rijeka, Rijeka, Not set
University Hospital Center Zagreb, Zagreb, Not set
Klinicka bolnica Dubrava, Zagreb, Not set
Klinicka bolnica Merkur, Zagreb, Not set
Fakultní nemocnice Brno Bohunice, Brno, Brno-město
Fakultni nemocnice Olomouc, Olomouc, Olomoucký KRAJ
Fakultni nemocnice Kralovske Vinohrady, Prague, Praha 10
Vseobecna fakultni nemocnice v Praze, Praha 2, Not set
Rigshospitalet, Copenhagen, Hovedstaden
Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland
Aalborg Universitetshospital, Syd, Aalborg, Nordjylland
Tampereen yliopistollinen sairaala, Tampere, Pirkanmaa
Oulun yliopistollinen sairaala, Oulu, Pohjois-pohjanmaa
Kuopion Yliopistollinen Sairaala, Kuopio, Pohjois-savo
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Uusimaa
Turku University Hospital, Turku, Varsinais-suomi
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice, Alpes-maritimes
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE, Toulouse, Haute-garonne
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandoeuvre lès Nancy, Lorraine
Centre Hospitalier de Dunkerque, Dunkirk, Nord-pas-de-calais
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes, Pays-de-la-loire
Hôpital NOVO, Cergy Pontoise, Val-d'oise
Hôpital NOVO, Pontoise, Val-d'oise
Henri Mondor Hospital, Créteil, Val-de-marne
CHD Vendee, La Roche-sur-Yon, Vendée
Centre Hospitalier de la Côte Basque, Bayonne, Not set
Centre Hospitalier du Mans, Le Mans, Not set
Hôpital Universitaire Necker Enfants Malades, Paris, Not set
Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set
Centre Hospitalier de Cornouaille, Quimper, Not set
Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau, Tours, Not set
Centre Hospitalier Bretagne Atlantique, Vannes, Not set
Centre Hospitalier Bretagne Atlantique, Vannes, Not set
Universitaetsklinikum Freiburg, Freiburg, Baden-württemberg
Robert Bosch Krankenhaus GmbH, Stuttgart, Baden-württemberg
Universitaetsklinikum Ulm, Ulm, Baden-württemberg
Klinikum Nürnberg Nord, Nürnberg, Bayern
Universitätsklinikum Bonn, Bonn, Nordrhein-westfalen
Universitätsklinikum Jena, Jena, Thüringen
Vivantes Klinikum Am Urban, Berlin, Not set
Vivantes Klinikum Am Urban, Berlin, Not set
Medizinische Universität Lausitz - Carl Thiem, Cottbus, Not set
Asklepios Altona, Hamburg, Not set
St. Barbara-Klinik Hamm-Heessen, Hamm, Not set
Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Not set
University Hospital of Alexandroupolis, Alexandroupolis, Anatolikí Makedonía KAI Thráki
Evangelismos General Hospital of Athens, Athens, Attikí
Alexandra General Hospital of Athens, Athens, Attikí
"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía
G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki
University Hospital of Ioannina, Ioannina, Ípeiros
Soroka Medical Center, Be'er Sheva, Hadarom
Rabin Medical Center, Petah-Tikva, Hamerkaz
Sheba Medical Center, Ramat Gan, Hamerkaz
Sourasky Medical Center, Tel Aviv, Tell Abīb
Hadassah Medical Center, Jerusalem, Yerushalayim
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-romagna
P.O. San Carlo Borromeo- ASST SANTI PAOLO E CARLO, Milano, Lombardia
Azienda Ospedaliero Universitaria delle Marche, Ancona, Marche
Azienda Socio Sanitaria Ovest milanese, Legnano, Milano
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Piemonte
A.O.U. Policlinico Paolo Giaccone, Palermo, Sicilia
Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana
Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set
Istituto Europeo di Oncologia IRCCS, Milano, Not set
Ospedale Civile dello Spirito Santo, Pescara, Not set
Nagoya City University Hospital, Nagoya, Aichi
Toyohashi Municipal Hospital, Toyohashi, Aichi
Ehime Prefectural Central Hospital, Matsuyama, Ehime
Ogaki Municipal Hospital, Ogaki, Gifu
Gunma University Hospital, Maebashi, Gunma
National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma
Kobe City Medical Center General Hospital, Kobe, Hyogo
Iwate Medical University Hospital, Shiwa-gun Yahaba-cho, Iwate
Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka
Nippon Medical School Hospital, Bunkyo-ku, Tokyo
Japanese Foundation for Cancer Research, Koto, Tokyo
Yamanashi Prefectural Central Hospital, Kofu-shi, Yamanashi
Kagoshima University Hospital, Kagoshima, Not set
University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set
National Hospital Organization Okayama Medical Center, Okayama, Not set
Okayama Rosai Hospital, Okayama, Not set
Yamagata University Hospital, Yamagata, Not set
Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [seoul]
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [seoul]
Maastricht UMC+, Maastricht, Limburg
Albert Schweitzer Ziekenhuis, locatie Dordwijk, Dordrecht, Zuid-holland
Akershus Universitetssykehus, Lørenskog, Akershus
St. Olavs Hospital, Trondheim, Sør-trøndelag
Sykehuset i Vestfold, Tønsberg, Vestfold
Oslo Universitetssykehus Ullevål, Oslo, Not set
2Ca Braga, Braga, Not set
Univerzitna nemocnica Martin, Martin, Zilinsky
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banska Bystrica, Not set
Institut Català d'Oncologia (ICO) - Badalona, Badalona, Barcelona [barcelona]
Hospital Universitari Mutua Terrassa, Terrassa, Barcelona [barcelona]
Hospital General Universitario Morales Meseguer, Murcia, Galicia [galicia]
Institut Català d'Oncologia (ICO) - Girona, Girona, Girona [gerona]
Hospital Universitario Infanta Leonor, Madrid, Madrid, Comunidad DE
OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces, Barakaldo, PAÍS Vasco
ASCIRES ECG Médica S.L, València, Valenciana, Comunitat
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Universitario HM Sanchinarro, Madrid, Not set
H.R.U Málaga - Hospital General, Málaga, Not set
Centro de Diagnóstico y Resonancia Magnética, Salamanca, Not set
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set
Hospital Universitari i Politecnic La Fe, València, Not set
Falu Lasarett, Falun, Not set
Universitetssjukhuset Örebro, Örebro, Örebro LÄN [se-18]
China Medical University Hospital, Taichung, Not set
Milton Keynes Hospital, Milton Keynes, Buckinghamshire
Glan Clwyd Hospital, Bodelwyddan, Denbighshire [SIR Ddinbych Gb-ddb]
Royal Bournemouth Hospital, Bournemouth, Dorset
Poole Hospital, Poole, Dorset
Eastbourne District General Hospital, Eastbourne, EAST Sussex
Queen Elizabeth Hospital Birmingham, Birmingham, England
Maidstone Hospital, Maidstone, Kent
St Bartholomew's Hospital, London, London, CITY OF
Guy's & St Thomas' NHS Foundation Trust, London, London, CITY OF
King's College Hospital, London, London, CITY OF
Hammersmith Hospital, London, London, CITY OF
Churchill Hospital, Oxford, Oxfordshire
Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire
Royal Marsden Hospital (Sutton), London, Sutton
Kent and Canterbury Hospital, Canterbury, Not set
New Cross Hospital, Wolverhampton, Not set
Conditions: Multiple Myeloma
301 - 312 of 3905